-
2024
- New advances in genomics and epigenetics in antiphospholipid syndrome.
López-Pedrera C, Cerdó T, Jury EC, Muñoz-Barrera L, Escudero-Contreras A, Aguirre MA, Pérez-Sánchez C
Rheumatology (Oxford). 2024 Feb 6. doi: 10.1093/rheumatology/kead575
- Exploring candidate biomarkers for rheumatoid arthritis through cardiovascular and cardiometabolic serum proteome profiling.
Cuesta-López L, Escudero-Contreras A, Hanaee Y, Pérez-Sánchez C, Ruiz-Ponce M, Martínez-Moreno JM, Pérez-Pampin E, González A, Plasencia-Rodriguez C, Martínez-Feito A, Balsa A, López-Medina C, Ladehesa-Pineda L, Rojas-Giménez M, Ortega-Castro R, Calvo-Gutiérrez J, López-Pedrera C, Collantes-Estévez E, Arias-de la Rosa I, Barbarroja N.
Front Immunol. 2024 Feb 14. doi: 10.3389/fimmu.2024.1333995
- Personalized cardiovascular risk assessment in Rheumatoid Arthritis patients using circulating molecular profiles and their modulation by TNFi, IL6Ri, and JAKinibs.
Muñoz-Barrera L, Perez-Sanchez C, Ortega-Castro R, Corrales S, Luque-Tevar M, Cerdó T, Sanchez-Pareja I, Font P, Lopez-Mejías R, Calvo J, Abalos-Aguilera MC, Ruiz-Vilchez D, Segui P, Merlo C, Perez-Venegas J, Ruiz Montesino MD, Rodriguez-Escalera C, Barco CR, Fernandez-Nebro A, Vazque NM, Marenco JL, Montañes JU, Godoy-Navarrete J, Cabezas-Lucena AM, Estevez EC, Aguirre MA, González-Gay MA, Barbarroja N, Escudero-Contreras A, Lopez-Pedrera C
Biomed Pharmacother. 2024 Apr. doi: 10.1016/j.biopha.2024.116357
- Exploring the unifying concept of Spondyloarthritis: a latent class analysis of the REGISPONSER registry.
Michelena X, Sepriano A, Zhao SS, López-Medina C, Collantes-Estévez E, Font-Ugalde P, Juanola X, Marzo-Ortega H
Rheumatology (Oxford). 2024 Jan 17. doi: 10.1093/rheumatology/keae005
- Sex differential impact of comorbidities in spondyloarthritis: data from COMOSPA study.
Llop M, Gratacós J, Moreno M, Arevalo Salaet M, Calvet J, Berenguer-Llergo A, Dougados M, Molto A, López-Medina C
RMD Open. 2024 Jan 30. doi: 10.1136/rmdopen-2023-003776
- Exploring the influence of baseline rheumatoid factor levels on TNF inhibitor retention rate in patients with rheumatoid arthritis: a multicentre and retrospective study.
López-Medina C, Calvo-Gutiérrez J, Ábalos-Aguilera MC, Cepas F, Plasencia-Rodríguez C, Martínez-Feito A, Balsa A, Faré-García R, Juan-Mas A, Ruiz-Esquide V, Sainz L, Díaz-Torné C, Godoy-Navarrete FJ, Añón-Oñate I, Mena-Vázquez N, Manrique-Arija S, Moreno-García MS, Ortega-Castro R, Escudero-Contreras A.
RMD Open. 2024 Feb 23. doi: 10.1136/rmdopen-2023-003975
- Impact of multimorbidity on the first ts/bDMARD effectiveness and retention rate after two years of follow-up in patients with rheumatoid arthritis from the BIOBADASER registry.
Calvo-Gutiérrez J, López-Medina C, Otero-Varela L, Escudero-Contreras A, Ortega-Castro R, Ladehesa-Pineda L, Campos C, Bernabeu-Gonzalvez P, Pérez-Gómez A, García-Dorta A, Ruiz-Montesino D, Pombo-Suarez M, Ros-Vilamajo I, Sánchez-Alonso F, Castrejón I
Arthritis Res Ther. 2024 Feb 23. doi: 10.1186/s13075-024-03287-9
- Sacroiliac radiographic progression over 10 years in axSpA: data from the DESIR inception cohort.
Molto A, López-Medina C, Sepriano A, Ramiro S, de Hooge M, van Lunteren M, Navarro-Compán V, Wendling D, Dougados M
Ann Rheum Dis. 2024 Jun 12. doi: 10.1136/ard-2023-225184
- Bone metabolism and inflammatory biomarkers in radiographic and non-radiographic axial spondyloarthritis patients: a comprehensive evaluation.
Gómez-García I, Ladehesa-Pineda ML, Diaz-Tocados JM, López-Medina C, Abalos-Aguilera MC, Ruiz-Vilches D, Paz-Lopez G, Gonzalez-Jimenez A, Ranea JAG, Escudero-Contreras A, Moreno-Indias I, Tinahones FJ, Collantes-Estévez E, Ruiz-Limón P
Front Endocrinol (Lausanne). 2024 Feb 15. doi: 10.3389/fendo.2024.1227196
- Disease activity and widespread pain are main contributors to patient-reported global health in axial spondyloarthritis: an analysis of 6064 patients.
Drouet J, López-Medina C, Granger B, Fautrel B, Landewe RBM, Molto A, Gaujoux-Viala C, Kiltz U, Dougados M, Gossec L
Rheumatol Int. 2024 Apr 10. doi: 10.1007/s00296-024-05576-7
- Different Therapeutic Response to Anti-TNF Drugs in Patients with Axial Spondyloarthritis Depending on Their Clinical Profile: An Unsupervised Cluster Analysis.
Priego-Pérez C, Puche-Larrubia MÁ, Ladehesa-Pineda L, Calvo-Guitérrez J, Ortega-Castro R, Escudero-Contreras A, Barbarroja N, Collantes-Estévez E, López-Medina C
J Clin Med. 2024 Mar 23. doi: 10.3390/jcm13071855
- Comparing clinical profiles in spondyloarthritis with Crohn's disease or ulcerative colitis: insights from the ASAS-PerSpA study.
Rios Rodriguez V, Duran TI, Torgutalp M, López-Medina C, Dougados M, Kishimoto M, Ono K, Protopopov M, Haibel H, Rademacher J, Poddubnyy D, Proft F
Rheumatol Adv Pract. 2024 May 22. doi: 10.1093/rap/rkae064. eCollection 2024
- Translation and cross-cultural adaptation of the modified Short Questionnaire to Assess Health-enhancing physical activity (mSQUASH) into French language.
López-Medina C, Ramiro S, Durme CV, Ez-Zaitouni Z, Toukap AN, Arends S, Spoorenberg A, Fogel O, Moltó A
Joint Bone Spine. 2024 Jun 10. doi: 10.1016/j.jbspin.2024.105749
- Personalized cardiovascular risk assessment in Rheumatoid Arthritis patients using circulating molecular profiles and their modulation by TNFi, IL6Ri, and JAKinibs.
Muñoz-Barrera L, Perez-Sanchez C, Ortega-Castro R, Corrales S, Luque-Tevar M, Cerdó T, Sanchez-Pareja I, Font P, Lopez-Mejías R, Calvo J, Abalos-Aguilera MC, Ruiz-Vilchez D, Segui P, Merlo C, Perez-Venegas J, Ruiz Montesino MD, Rodriguez-Escalera C, Barco CR, Fernandez-Nebro A, Vazque NM, Marenco JL, Montañes JU, Godoy-Navarrete J, Cabezas-Lucena AM, Estevez EC, Aguirre MA, González-Gay MA, Barbarroja N, Escudero-Contreras A, Lopez-Pedrera C
Biomed Pharmacother. 2024 Apr. doi: 10.1016/j.biopha.2024.116357
2023
- Decoding clinical and molecular pathways of liver dysfunction in Psoriatic Arthritis: Impact of cumulative methotrexate doses.
Ruiz-Ponce M, Cuesta-López L, López-Montilla MD, Pérez-Sánchez C, Ortiz-Buitrago P, Barranco A, Gahete MD, Herman-Sánchez N, Lucendo AJ, Navarro P, López-Pedrera C, Escudero-Contreras A, Collantes-Estévez E, López-Medina C, Arias-de la Rosa I, Barbarroja N
Biomed Pharmacother. 2023 Oct 30. doi: 10.1016/j.biopha.2023.115779
- Identification of the first signs or symptoms in different spondyloarthritis subtypes and their association with HLA-B27: data from REGISPONSER and RESPONDIA registries.
Puche-Larrubia MÁ, Ladehesa-Pineda L, Vázquez-Mellado J, Escudero-Contreras A, Gratacós J, Juanola X, Collantes-Estévez E, Font-Ugalde P, López-Medina C
RMD Open. 2023 Sep. doi: 10.1136/rmdopen-2023-003235
- Safe Treatment With Secukinumab in a Patient With Axial Spondyloarthritis and a History of a Leishmania donovani Infection.
López-Medina C, Doblas A, Escudero-Contreras A, Collantes-Estévez E
J Rheumatol. 2023 Sep 1. doi: 10.3899/jrheum.2023-0004
- Achilles enthesitis on physical examination leads to worse outcomes after 2 years of follow up in patients with ankylosing spondylitis from REGISPONSER-AS registry.
López-Medina C, Puche-Larrubia MÁ, Granados R, Ladehesa-Pineda L, Ruiz-Vilchez D, Ábalos-Aguilera MC, Font-Ugalde P, Collantes-Estévez E
Arthritis Res Ther. 2023 Jan 13. doi: 10.1186/s13075-023-02988-x
- Diagnostic delay is associated with uveitis and inflammatory bowel disease in AS: a study of extra-musculoskeletal manifestations in SpA.
Michelena X, Zhao SS, Marco-Pascual C, Almirall M, Collantes E, Font-Ugalde P, López-Medina C, Wei JC, Morgan AW, Rodríguez J, Juanola X, Vázquez-Mellado J, Marzo-Ortega H.
Rheumatology (Oxford). 2023 May 15. doi: 10.1093/rheumatology/kead225
- Enthesitis indices identify different patients with this characteristic in axial and peripheral spondyloarthritis and also in psoriatic arthritis: ASAS-PerSpA data.
Granados REM, Ladehesa-Pineda ML, Puche-Larrubia MÁ, Escudero-Contreras A, Dougados M, Collantes-Estevez E, López-Medina C
Arthritis Res Ther. 2023 Jun 8. doi: 10.1186/s13075-023-03080-0
- Evaluation of the agreement between the ACR 1990 fibromyalgia tender points and an enthesitis score in patients with axial spondyloarthritis.
Hamitouche F, Lopez-Medina C, Gossec L, Perrot S, Dougados M, Moltó A
Rheumatology (Oxford). 2023 Aug 1. doi: 10.1093/rheumatology/keac683
- Sex differences in cardiovascular and disease-related features in axial spondyloarthritis. A multicenter study of 912 patients.
Ferraz-Amaro I, Genre F, Blanco R, Corrales A, Mazón IG, Portilla V, Aurrecoechea E, Mata C, Hernández-Hernández V, Quevedo-Abeledo JC, Rodríguez-Lozano C, Lopez-Medina C, Ladehesa-Pineda ML, Castañeda S, Vicente EF, Fernández-Carballido C, Martínez-Vidal MP, Castro-Corredor D, Anino-Fernández J, Peiteado D, Plasencia-Rodríguez C, Vivar MLG, Galíndez-Agirregoikoa E, Vegas-Revenga N, Urionagüena-Onaindia I, Perez EM, Díaz CF, González-Gay MÁ, Rueda-Gotor J.
Semin Arthritis Rheum. 2023 Mar 29. doi: 10.1016/j.semarthrit.2023.152198
- Differences between early vs. late-onset of psoriatic arthritis: Data from the RESPONDIA and REGISPONSER registries.
Puche-Larrubia MÁ, Ladehesa-Pineda L, López-Montilla MD, Barbarroja N, Escudero-Contreras A, Vazquez-Mellado J, Collantes-Estévez E, López-Medina C
Joint Bone Spine. 2023 Mar 17. doi: 10.1016/j.jbspin.2023.105563
- Sex-specific metabolic adaptations in transgenic mice overexpressing cytochrome b5 reductase-3.
Sánchez-Mendoza LM, Pérez-Sánchez C, Rodríguez-López S, López-Pedrera C, Calvo-Rubio M, de Cabo R, Burón MI, González-Reyes JA, Villalba JM
Free Radic Biol Med. 2023 Jul 16. doi: 10.1016/j.freeradbiomed.2023.07.012
- Preclinical Characterization of Pharmacologic NAD+ Boosting as a Promising Therapeutic Approach in Rheumatoid Arthritis.
Perez-Sanchez C, Escudero-Contreras A, Cerdó T, Sánchez-Mendoza LM, Llamas-Urbano A, la Rosa IA, Pérez-Rodriguez M, Muñoz-Barrera L, Del Carmen Abalos-Aguilera M, Barbarroja N, Calvo J, Ortega-Castro R, Ruiz-Vilchez D, Moreno JA, Burón MI, González-Reyes JA, Collantes-Estevez E, Lopez-Pedrera C, Villalba JM.
Arthritis Rheumatol. 2023 Apr 24. doi: 10.1002/art.42528
- Characterization of the inflammatory proteome of synovial fluid from patients with psoriatic arthritis: Potential treatment targets.
Barbarroja N, López-Montilla MD, Cuesta-López L, Pérez-Sánchez C, Ruiz-Ponce M, López-Medina C, Ladehesa-Pineda ML, López-Pedrera C, Escudero-Contreras A, Collantes-Estévez E, Arias-de la Rosa I.
Front Immunol. 2023 Mar 22. doi: 10.3389/fimmu.2023.1133435
- Clinical features and immune mechanisms directly linked to the altered liver function in patients with rheumatoid arthritis.
Arias-de la Rosa I, Ruiz-Ponce M, Cuesta-López L, Pérez-Sánchez C, Leiva-Cepas F, Gahete MD, Navarro P, Ortega R, Cordoba J, Pérez-Pampin E, González A, Lucendo AJ, Collantes-Estévez E, López-Pedrera C, Escudero-Contreras A, Barbarroja N
Eur J Intern Med. 2023 Aug 4. doi: 10.1016/j.ejim.2023.08.002
- Damage measured by damage index for antiphosphlipid syndrome in antiphospholipid antibody-positive patients included in APS ACTION Registry.
Balbi GGM, Ahmadzadeh Y, Tektonidou MG, Pengo V, Sciascia S, Ugarte A, Belmont HM, Lopez-Pedrera C, Fortin PR, Wahl D, Gerosa M, de Jesús GR, Ji L, Atsumi T, Efthymiou M, Branch DW, Nalli C, Almaraz ER, Petri M, Cervera R, Knight JS, Artim-Esen B, Willis R, Bertolaccini ML, Cohen H, Roubey R, Erkan D, Andrade D; AntiPhospholipid Syndrome Alliance for Clinical Trials and International Networking (APS ACTION) Clinical Database and Repository (APS ACTION)
Rheumatology (Oxford). 2023 Jun 12. doi: 10.1093/rheumatology/kead292
- Splicing machinery is profoundly altered in systemic lupus erythematosus and antiphospholipid syndrome and directly linked to key clinical features.
Lopez-Pedrera C, Patiño-Trives AM, Cerdó T, Ortega-Castro R, Sanchez-Pareja I, Ibañez-Costa A, Muñoz-Barrera L, Ábalos-Aguilera MC, Ruiz-Vilchez D, Seguí Azpilcueta P, Espinosa M, Barbarroja N, Escudero-Contreras A, Castaño JP, Luque RM, Ortega R, Aguirre MA, Perez-Sanchez C.
J Autoimmun. 2023 Jan 6. doi: 10.1016/j.jaut.2022.102990
- The thrombus proteome in stroke reveals a key role of the innate immune system and new insights associated with its etiology, severity, and prognosis.
Lopez-Pedrera C, Oteros R, Ibáñez-Costa A, Luque-Tévar M, Muñoz-Barrera L, Barbarroja N, Chicano-Gálvez E, Marta-Enguita J, Orbe J, Velasco F, Perez-Sanchez C
J Thromb Haemost. 2023 Apr 25. doi: 10.1016/j.jtha.2023.04.015
- Peripheral spondyloarthritis: What have we learned?
Puche-Larrubia MÁ, López-Medina C, Ziadé N.
Best Pract Res Clin Rheumatol. 2023 Aug 18:101862. doi: 10.1016/j.berh.2023.101862
- Clinical profile and treatment utilisation based on HLA-B*27 status in axial spondyloarthritis: results from ASAS-PerSpA study.
Chaudhary H, López-Medina C, Khan MA, Dougados M, Magrey M
RMD Open. 2023 Jul. doi: 10.1136/rmdopen-2023-003179
2022
- Characterising the axial phenotype of psoriatic arthritis: a study comparing axial psoriatic arthritis and ankylosing spondylitis with psoriasis from the REGISPONSER registry.
Michelena X, López-Medina C, Erra A, Juanola X, Font-Ugalde P, Collantes E, Marzo-Ortega H.
RMD Open. 2022 Dec. doi: 10.1136/rmdopen-2022-002513
- Association between HLA-B27 and peripheral spondyloarthritis phenotype: results from the ASAS perSpA study.
Benavent D, Capelusnik D, Ramiro S, Molto A, López-Medina C, Dougados M, Navarro-Compán V
RMD Open. 2022 Sep. doi: 10.1136/rmdopen-2022-002514
- Defining the Role of Monocytes in Sjögren's Syndrome.
Sequí-Sabater JM, Beretta L
2022 Oct 23. doi: 10.3390/ijms232112765
- Risankizumab: Efficacy, Safety, and Survival in the Mid-Term (52 Weeks) in Real Clinical Practice in Andalusia, Spain, According to the Therapeutic Goals of the Spanish Psoriatic Guidelines.
Ruiz-Villaverde R, Rodriguez-Fernandez-Freire L, Pérez-Gil A, Font-Ugalde P, Galán-Gutiérrez M
Life. 2022 Nov 14. doi: 10.3390/life12111883
- miR-374a-5p regulates inflammatory genes and monocyte function in patients with inflammatory bowel disease.
Perez-Sanchez C, Barbera Betancourt A, Lyons PA, Zhang Z, Suo C, Lee JC, McKinney EF, Modis LK, Ellson C, Smith KGC
Journal of Experimental Medicine. 2022 Apr 1. doi: 10.1084/jem.20211366
- Maternal factors associated with smoking during gestation and consequences in newborns: Results of an 18-year study.
Sequí-Canet JM, Sequí-Sabater JM, Marco-Sabater A, Corpas-Burgos F, Collar Del Castillo JI, Orta-Sibú N
Journal of Clinical and Translational Research. 2022 Jan 3. doi: 10.18053/jctres.08.202201.001
- Editorial: Clinical management, pathogenesis and biomarkers of cardiovascular disease associated with systemic autoimmune disorders.
Perez-Sanchez C, Pineda-Torra I, Lopez-Pedrera C
Frontiers in Immunology. 2022 Nov 23. doi: 10.3389/fimmu.2022.1085875
- Editorial: Clinical manifestations and comorbidities in axial and peripheral spondyloarthritis.
Schiotis RE, Collantes-Estévez E, López-Medina C.
Frontiers in Medicine. 2022 Aug 12. doi: 10.3389/fmed.2022.980732
- Effectiveness and safety of tocilizumab in monotherapy in biologic-naïve and non-naïve patients with rheumatoid arthritis in a real-world setting.
Marsal Barril S, Martin-Martinez MA, Blanco-Garcia FJ, Fernández-Nebro A, García de Vicuña R, Tornero-Molina J, Sánchez-Alonso F, Novella-Navarro M, Escudero-Contreras A, Alegre-Sancho JJ, Urruticoechea-Arana A, Bustabad-Reyes MS, Trenor-Larraz P, Pérez-Sandoval T, Tevar-Sánchez MI, Sánchez-Costa JT, Raya-Álvarez E
Reumatoloía Clínica. 2022 Dec. doi: 10.1016/j.reumae.2021.12.004
- ASAS-EULAR recommendations for the management of axial spondyloarthritis: 2022 update.
Ramiro S, Nikiphorou E, Sepriano A, Ortolan A, Webers C, Baraliakos X, Landewé RBM, Van den Bosch FE, Boteva B, Bremander A, Carron P, Ciurea A, van Gaalen FA, Géher P, Gensler L, Hermann J, de Hooge M, Husakova M, Kiltz U, López-Medina C, Machado PM, Marzo-Ortega H, Molto A, Navarro-Compán V, Nissen MJ, Pimentel-Santos FM, Poddubnyy D, Proft F, Rudwaleit M, Telkman M, Zhao SS, Ziade N, van der Heijde D
Annals of the Rheumatic Diseases. 2022 Oct 21. doi: 10.1136/ard-2022-223296.
- Geographical prevalence of family history in patients with axial spondyloarthritis and its association with HLA-B27 in the ASAS-PerSpA study.
Boel A, van Lunteren M, López-Medina C, Sieper J, van der Heijde D, van Gaalen FA
Rheumatic and Musculoskeletal Diseasaes. 2022 Mar. doi: 10.1136/rmdopen-2021-002174
- Factors associated with atherosclerosis in radiographic and non-radiographic axial spondyloarthritis. A multicenter study on 838 patients.
Rueda-Gotor J, Ferraz-Amaro I, Genre F, González-Mazón I, Corrales A, Calvo-Rio V, Portilla V, Llorca J, Expósito R, Hernández-Hernández V, Quevedo-Abeledo JC, Rodríguez-Lozano C, Lopez-Medina C, Ladehesa-Pineda ML, Castañeda S, Vicente EF, Fernández-Carballido C, Martínez-Vidal MP, Castro-Corredor D, Anino-Fernández J, Peiteado D, Plasencia-Rodríguez C, García-Vivar ML, Galíndez-Agirregoikoa E, Montes-Perez E, Fernández-Díaz C, Blanco R, González-Gay MÁ.
Seminars in Arthritis and Rheumatism. 2022 May 28. doi: 10.1016/j.semarthrit.2022.152037
- Axial Disease in Psoriatic Arthritis: how can we Define it, and does it have an Impact on Treatment?
Lopez-Medina C, Ziade N
Mediterranean Journal of Rheumatology. 2022 Apr 15. doi: 10.31138/mjr.33.1.142
- Cardiovascular and disease-related features associated with extra-articular manifestations in axial spondyloarthritis. A multicenter study of 888 patients.
Rueda-Gotor J, Ferraz-Amaro I, Genre F, González Mazón I, Corrales A, Portilla V, Llorca J, Agudo-Bilbao M, Aurrecoechea E, Expósito R, Hernández-Hernández V, Quevedo-Abeledo JC, Rodríguez-Lozano C, Lopez-Medina C, Ladehesa-Pineda ML, Castañeda S, Vicente EF, Fernández-Carballido C, Martínez-Vidal MP, Castro-Corredor D, Anino-Fernández J, Peiteado D, Plasencia-Rodríguez C, Vivar MLG, Galíndez-Agirregoikoa E, Perez EM, Fernández Díaz C, Blanco R, González-Gay MÁ
Seminars in Arthritis and Rheumatism. 2022 Sep 9. doi: 10.1016/j.semarthrit.2022.152096
- Immunosuppression use in primary antiphospholipid antibody-positive patients: Descriptive analysis of the AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) Clinical Database and Repository ("Registry").
Erton ZB, K Leaf R, de Andrade D, Clarke AE, Tektonidou MG, Pengo V, Sciascia S, Ugarte A, Belmont HM, Gerosa M, Fortin PR, Lopez-Pedrera C, Atsumi T, Zhang Z, Cohen H, Ramires de Jesús G, Branch DW, Wahl D, Andreoli L, Rodriguez-Almaraz E, Petri M, Barilaro G, Zuo Y, Artim-Esen B, Willis R, Quintana R, Vendramini MB, Barber MW, Bertolaccini ML, Roubey R, Erkan D
Lupus. 2022 Oct 7. doi: 10.1177/09612033221128742
- Pregnancy outcomes in antiphospholipid antibody positive patients: prospective results from the AntiPhospholipid Syndrome Alliance for Clinical Trials and InternatiOnal Networking (APS ACTION) Clinical Database and Repository ('Registry').
Erton ZB, Sevim E, de Jesús GR, Cervera R, Ji L, Pengo V, Ugarte A, Andrade D, Andreoli L, Atsumi T, Fortin PR, Gerosa M, Zuo Y, Petri M, Sciascia S, Tektonidou MG, Aguirre-Zamorano MA, Branch DW, Erkan D APS ACTION
Lupus Science & Medicine. 2022 Jun. doi: 10.1136/lupus-2021-000633
- Splicing machinery is impaired in rheumatoid arthritis, associated with disease activity and modulated by anti-TNF therapy.
Ibáñez-Costa A, Perez-Sanchez C, Patiño-Trives AM, Luque-Tevar M, Font P, Arias de la Rosa I, Roman-Rodriguez C, Abalos-Aguilera MC, Conde C, Gonzalez A, Pedraza-Arevalo S, Del Rio-Moreno M, Blazquez-Encinas R, Segui P, Calvo J, Ortega Castro R, Escudero-Contreras A, Barbarroja N, Aguirre MA, Castaño JP, Luque RM, Collantes-Estevez E, Lopez-Pedrera C
Annals of the Rheumatic Diseases. 2022 Jan. doi: 10.1136/annrheumdis-2021-220308
- Evidence for the Use of Secukinumab in Patients with Radiographic and Non-radiographic Axial Spondyloarthritis in the Last 5 Years.
Aparicio M, Guillén-Astete CA, López-Medina C, Sastre C, Rodríguez Martínez FJ
Rheumatology and Therapy. 2022 Feb. doi: 10.1007/s40744-021-00400-1
- Impact of a clinical pharmacist in a multidisciplinary consultation on the switch to a biosimilar for inflammatory rheumatic diseases.
Levivien C, Bottois C, López Medina C, Dumas S, Hubert J, Belo S, Roux C, Conort O, Dougados M
Joint Bone Spine. 2022 May. doi: 10.1016/j.jbspin.2021.105322
- Understanding the Disease Burden of Unemployed Patients With Axial Spondyloarthritis: Results From the Spanish Atlas 2017.
Garrido-Cumbrera M, Collantes-Estevez E, Navarro-Compán V, Zarco-Montejo P, Sastre C, Correa-Fernández J, Sanz-Gómez S, Plazuelo-Ramos P, Gratacos J
The Journal of Rhematology. 2022 Apr. doi: 10.3899/jrheum.210655
- Impact of the number of comorbidities on the outcome measures and on the retention rate of the first anti-TNF in patients with Ankylosing Spondylitis. Two-year follow-up in REGISPONSER-AS.
Puche-Larrubia MÁ, Ladehesa-Pineda L, Gómez-García I, Font-Ugalde P, Escudero-Contreras A, Collantes-Estévez E, López-Medina C; REGISPONSER study group
Seminars in Arthritis and Rheumatism. 2022 Feb. doi: 10.1016/j.semarthrit.2021.12.007
- Subclinical Atherosclerosis Measure by Carotid Ultrasound and Inflammatory Activity in Patients with Rheumatoid Arthritis and Spondylarthritis.
Rojas-Giménez M, López-Medina C, Ladehesa-Pineda ML, Puche-Larrubia MÁ, Gómez-García I, Calvo-Gutiérrez J, Seguí-Azpilcueta P, Ábalos-Aguilera MDC, Ruíz-Vilchez D, Escudero-Contreras A, Collantes-Estévez E
Journal of Clinical Medicine. 2022 Jan 27. doi: 10.3390/jcm11030662
- The clinical and molecular cardiometabolic fingerprint of an exploratory psoriatic arthritis cohort is associated with the disease activity and differentially modulated by methotrexate and apremilast.
Arias de la Rosa I, López-Montilla MD, Román-Rodríguez C, Pérez-Sánchez C, Gómez-García I, López-Medina C, Ladehesa-Pineda ML, Ábalos-Aguilera MDC, Ruiz D, Patiño-Trives AM, Luque-Tévar M, Añón-Oñate I, Pérez-Galán MJ, Guzmán-Ruiz R, Malagón MM, López-Pedrera C, Escudero-Contreras A, Collantes-Estévez E, Barbarroja N
Journal of Internal Medicine. 2022 Mar 02. doi: 10.1111/joim.13447
- The impact of psoriasis on the clinical characteristics, disease burden and treatment patterns of peripheral spondyloarthritis.
Izci Duran T, Torgutalp M, Rios Rodriguez V, Proft F, López-Medina C, Dougados M, Poddubnyy D
Rheumatology. 2022 Apr 22. doi: 10.1093/rheumatology/keac235
- What is peripheral spondyloarthritis? Identifying proportion, phenotype and burden in post hoc analysis of the ASAS-PerSpA study.
Ziade N, Rassi J, Elzorkany B, Lopez-Medina C, Gamal SM, Hlais S, Dougados M, Baraliakos X
Seminars in Arthritis and Rheumatism. 2022 Apr 21. doi: 10.1016/j.semarthrit.2022.152012
- Clinical characteristics of patients with spondyloarthritis and inflammatory bowel disease versus inflammatory bowel disease-related arthritis.
Ono K, Kishimoto M, Deshpande GA, Fukui S, Kawaai S, Sawada H, Matsuura M, Rodriguez VR, Proft F, Tada K, Tamura N, Taniguchi Y, Hirata A, Kameda H, Tsuji S, Kaneko Y, Dobashi H, Okano T, Haji Y, Morita A, Okada M, Komagata Y, Lopez-Medina C, Molto A, Dougados M, Hisamatsu T, Tomita T, Kaname S
Rheumatology International. 2022 Oct. doi: 10.1007/s00296-022-05117-0
- Tender to touch-Prevalence and impact of concomitant fibromyalgia and enthesitis in spondyloarthritis: An ancillary analysis of the ASAS PerSpA study.
Fitzgerald GE, Maguire S, Lopez-Medina C, Dougados M, O'Shea FD, Haroon N
Joint Bone Spine. 2022 May 27. doi: 10.1016/j.jbspin.2022.105420
- Irisin as a Novel Biomarker of Subclinical Atherosclerosis, Cardiovascular Risk and Severe Disease in Axial Spondyloarthritis.
Remuzgo-Martínez S, Rueda-Gotor J, Pulito-Cueto V, López-Mejías R, Corrales A, Lera-Gómez L, Pérez-Fernández R, Portilla V, González-Mazón Í, Blanco R, Expósito R, Mata C, Llorca J, Hernández-Hernández V, Rodríguez-Lozano C, Barbarroja N, Ortega-Castro R, Vicente E, Fernández-Carballido C, Martínez-Vidal MP, Castro-Corredor D, Anino-Fernández J, Peiteado D, Plasencia-Rodríguez C, Galíndez-Agirregoikoa E, García-Vivar ML, Vegas-Revenga N, Urionaguena I, Gualillo O, Quevedo-Abeledo JC, Castañeda S, Ferraz-Amaro I, González-Gay MÁ, Genre F
Frontiers in Immunology. 2022 Jul 8. doi: 10.3389/fimmu.2022.894171
- Validation of the French version of the Compliance Questionnaire for Rheumatology (CQR-5), a self-reporting questionnaire specific to patients with chronic inflammatory rheumatic disease.
Cavagna P, Hubert J, Bottois C, Lopez-Medina C, Roux C, Conort O, Dougados M
Joint Bone Spine. 2022 Aug 6. doi: 10.1016/j.jbspin.2022.105449
- Pathogenic mechanisms involving the interplay between adipose tissue and auto-antibodies in rheumatoid arthritis.
Arias-de la Rosa I, Escudero-Contreras A, Ruiz-Ponce M, Cuesta-López L, Román-Rodríguez C, Pérez-Sánchez C, Ruiz-Limón P, Ruiz RG, Leiva-Cepas F, Alcaide J, Segui P, Plasencia C, Martinez-Feito A, Font P, Ábalos MC, Ortega R, Malagón MM, Tinahones FJ, Collantes-Estévez E, López-Pedrera C, Barbarroja N
IScience. 2022 Sep 16. doi: 10.1016/j.isci.2022.104893
- Relationship between onset of psoriasis and spondyloarthritis symptoms with clinical phenotype and diagnosis: data from REGISPONSER registry.
Gómez-Garcia I, García-Puga T, Font-Ugalde P, Puche-Larrubia MA, Barbarroja N, Ruiz-Limón P, Escudero-Contreras A, Collantes-Estévez E, López-Medina C
Therapeutic Advances in Musculoskeletal Disease. 2022 Aug 22. doi: 10.1177/1759720X221118055
- Smoking and alcohol consumption are associated with peripheral musculoskeletal involvement in patients with spondyloarthritis (including psoriatic arthritis). Results from the ASAS-PerSpA study.
Ladehesa-Pineda ML, Ortega-Castro R, Puche-Larrubia MÁ, Granados REM, Dougados M, Collantes-Estévez E, López-Medina C
Seminars in Arthritis and Rheumatism. 2022 Nov 30. doi: 10.1016/j.semarthrit.2022.152146
- Disease activity at conception predicts lupus flare up to two years after birth: A multicentre long term follow-up study.
Radin M, Schreiber K, Cecchi I, Signorelli F, de Jesús G, Aso K, Kono M, Urban ML, Bacco B, Gallo Cassarino S, Lo Sardo L, Foddai SG, Barinotti A, Gómez-García I, Quaglia MI, Tissera Y, Gervasoni F, Aguirre-Zamorano MÁ, Alba P, Benedetto C, Atsumi T, Amengual O, Emmi G, Andrade D, Marozio L, Roccatello D, Sciascia S
Seminars in Arthritis and Rheumatism. 2022 Oct 22. doi: 10.1016/j.semarthrit.2022.152113
- Nonalcoholic fatty liver disease in inflammatory arthritis: Relationship with cardiovascular risk.
Barbarroja N, Ruiz-Ponce M, Cuesta-López L, Pérez-Sánchez C, López-Pedrera C, Arias-de la Rosa I, Collantes-Estévez E
Frontiers in Immunology. 2022 Sep 23. doi: 10.3389/fimmu.2022.997270
- Does gender influence outcome measures similarly in patients with spondyloarthritis? Results from the ASAS-perSpA study.
Benavent D, Capelusnik D, Ramiro S, Molto A, López-Medina C, Dougados M, Navarro-Compán V
RMD Open. 2022 Sep. doi: 10.1136/rmdopen-2022-002514
- Uveitis in peripheral spondyloarthritis patients: an ancillary analysis of the ASAS-PerSpA study.
Llop M, Gratacós J, Moreno M, Arévalo M, Calvet J, Dougados M, López-Medina C
Therapeutic Advances in Musculoskeletal Disease. 2022 Sep 5. doi: 10.1177/1759720X221119246
2021
- Elucidating the role of a positive family history in differentiating between axial and peripheral spondyloarthritis: an ancillary analysis of the ASAS-PerSpA study.
Kwan YH, Tan L, Tan CS, López-Medina C, Dougados M, Proft F, Rios-Rodriguez V, Phang JK, Chew EH, Østbye T, Thumboo J, Fong W.
Clin Exp Rheumatol. 2021 Dec 10. doi: 10.55563/clinexprheumatol/gqsd66
- Anti-dsDNA Antibodies Increase the Cardiovascular Risk in Systemic Lupus Erythematosus Promoting a Distinctive Immune and Vascular Activation.
Patiño-Trives AM, Pérez-Sánchez C, Pérez-Sánchez L, Luque-Tévar M, Ábalos-Aguilera MC, Alcaide-Ruggiero L, Arias-de la Rosa I, Román-Rodríguez C, Seguí P, Espinosa M, Font P, Barbarroja N, Escudero-Contreras A, Antonio González-Reyes J, Manuel Villalba J, Collantes-Estévez E, Aguirre-Zamorano MÁ, López-Pedrera C.
Arterioscler Thromb Vasc Biol. 2021 Jul 29. doi: 10.1161/ATVBAHA.121.315928
- Root joint involvement in spondyloarthritis: a post hoc analysis from the international ASAS-PerSpA study.
Ziadé N, El Hajj J, Rassi J, Hlais S, López-Medina C, Gamal SM, Elzorkany B, Dougados M, Baraliakos X
Rheumatology. 2021 Apr 26. doi: 10.1093/rheumatology/keab380
- Expression of DDX11 and DNM1L at the 12p11 Locus Modulates Systemic Lupus Erythematosus Susceptibility.
Saeed M, Ibáñez-Costa A, Patiño-Trives AM, Muñoz-Barrera L, Collantes Estévez E, Aguirre MÁ, López-Pedrera C
Int J Mol Sci. 2021 Jul 16. doi: 10.3390/ijms22147624
- Therapeutic Potential and Immunomodulatory Role of Coenzyme Q10 and Its Analogues in Systemic Autoimmune Diseases.
López-Pedrera C, Villalba JM, Patiño-Trives AM, Luque-Tévar M, Barbarroja N, Aguirre MÁ, Escudero-Contreras A, Pérez-Sánchez C
Antioxidants (Basel). 2021 Apr 13. doi: 10.3390/antiox10040600
- Clinical Utility of microRNAs in Exhaled Breath Condensate as Biomarkers for Lung Cancer.
Pérez-Sánchez C, Barbarroja N, Pantaleão LC, López-Sánchez LM, Ozanne SE, Jurado-Gámez B, Aranda E, Lopez-Pedrera C, Rodríguez-Ariza A
J Pers Med .2021 Feb 9. doi: 10.3390/jpm11020111
- A new molecular classification to drive precision treatment strategies in primary Sjögren's syndrome.
Soret P, Le Dantec C, Desvaux E, Foulquier N, Chassagnol B, Hubert S, Jamin C, Barturen G, Desachy G, Devauchelle-Pensec V, Boudjeniba C, Cornec D, Saraux A, Jousse-Joulin S, Barbarroja N, Rodríguez-Pintó I, De Langhe E, Beretta L, Chizzolini C, Kovács L, Witte T; PRECISESADS Clinical Consortium; PRECISESADS Flow Cytometry Consortium, Bettacchioli E, Buttgereit A, Makowska Z, Lesche R, Borghi MO, Martin J, Courtade-Gaiani S, Xuereb L, Guedj M, Moingeon P, Alarcón-Riquelme ME, Laigle L, Pers JO.
Nat Commun. 2021 Jun 10. doi: 10.1038/s41467-021-23472-7
- Impact of rheumatoid arthritis on sexuality: adaptation and validation of the Qualisex questionnaire for use in Spain.
Romera Baures M, Seoane-Mato D, Alegre-Sancho JJ, León L, Caracuel Ruiz MA, Calvo-Alen J, Stoye C, Fernández B, Núñez-Monje V, Freites-Núñez D, Ortega Castro R; Adaptación-Qualisex Study Group
Rheumatology International. 2021 Nov 16. doi: 10.1007/s00296-021-05043-7
- Recommendations for prevention of infection in systemic autoimmune rheumatic diseases.
Rúa-Figueroa Fernández de Larrinoa Í, Carreira PE, Brito García N, Díaz Del Campo Fontecha P, Pego Reigosa JM, Gómez Puerta JA, Ortega-Castro R, Tejera Segura B, Aguado García JM, Torre-Cisneros J, Valencia-Martín JL, Pereda CA, Nishishinya-Aquino MB, Otón Sánchez MT, Silva Fernández L, Maese Manzano J, Chamizo Carmona E, Correyero Plaza M - Reumatología Clínica. 2021 Oct 2. doi: 10.1016/j.reumae.2021.4.3
- Local adaptation of recommendation-based materials for shared decision-making and management of comorbidity in rheumatoid arthritis.
Álvaro Gracia JM, Barbazán C, García Llorente JF, Muñóz-Fernández S, Gómez Centeno A, Urruticoechea-Arana A, Caracuel MÁ, Loza E, Calvo-Alén J
Clinical and Experimental Rheumatology. 2021 Jun 26. doi: 10.55563/clinexprheumatol/kypaiv
- Root joint involvement in spondyloarthritis: a post hoc analysis from the international ASAS-PerSpA study.
Ziadé N, El Hajj J, Rassi J, Hlais S, López-Medina C, Gamal SM, Elzorkany B, Dougados M, Baraliakos X
Rheumatology. 2021 Apr 26. doi: 10.1093/rheumatology/keab380
- Adherence to and patient's knowledge of self-management of subcutaneous biologic therapy in chronic inflammatory rheumatic diseases: results of a multicentre cross-sectional study.
Gaud-Listrat V, Lopez-Medina C, Hudry C, Nguyen M, Lebrun-Foisnet A, Sacchi A, Labatide Alanore S, Dernis E, Le Devic P, Fechtenbaum J, Richard-Miceli C, Le Goux P, Dadoun S, Moltό A, Blanchais-Behr A, Neveu S, Benhamou M, Giraud B, Roux C, Dougados M; RHEVER network (Hospital and City in Rheumatology Network).
Clinical and Experimental Rheumatology. 2021 May 28. doi: 10.55563/clinexprheumatol/slk3yz
- Assessment of Subclinical Psychotic Symptoms in Patients with Rheumatoid Arthritis and Spondyloarthritis.
Prados-Ojeda JL, Luque-Luque R, Gordillo-Urbano RM, Guler I, López-Medina C, Collantes-Estévez E, Escudero-Contreras A
Journal of Clinical Medicine. 2021 Aug 4. doi: 10.3390/jcm10163461
- Evidence for the Use of Secukinumab in Patients with Radiographic and Non-radiographic Axial Spondyloarthritis in the Last 5 Years.
Aparicio M, Guillén-Astete CA, López-Medina C, Sastre C, Rodríguez Martínez FJ
Rheumatology and Therapy. 2021 Nov 21. doi: 10.1007/s40744-021-00400-1
- Identification of clinical phenotypes of peripheral involvement in patients with spondyloarthritis, including psoriatic arthritis: a cluster analysis in the worldwide ASAS-PerSpA study.
López-Medina C, Chevret S, Molto A, Sieper J, Duruöz T, Kiltz U, Elzorkany B, Hajjaj-Hassouni N, Burgos-Vargas R, Maldonado-Cocco J, Ziade N, Gavali M, Navarro-Compan V, Luo SF, Biglia A, Tae-Jong K, Kishimoto M, Pimentel-Santos FM, Gu J, Muntean L, van Gaalen FA, Geher P, Magrey M, Ibáñez-Vodnizza SE, Bautista- Molano W, Maksymowych W, Machado PM, Landewé R, van der Heijde D, Dougados M
RMD Open. 2021 Nov. doi: 10.1136/rmdopen-2021-001728
- Impact of a clinical pharmacist in a multidisciplinary consultation on the switch to a biosimilar for inflammatory rheumatic diseases.
Levivien C, Bottois C, Lopez-Medina C, Dumas S, Hubert J, Belo S, Roux C, Conort O, Dougados M
Joint Bone Spine. 2021 Dec 8. doi: 10.1016/j.jbspin.2021.105322
- Integrative Clinical, Molecular, and Computational Analysis Identify Novel Biomarkers and Differential Profiles of Anti-TNF Response in Rheumatoid Arthritis.
Luque-Tévar M, Perez-Sanchez C, Patiño-Trives AM, Barbarroja N, Arias de la Rosa I, Abalos-Aguilera MC, Marin-Sanz JA, Ruiz-Vilchez D, Ortega-Castro R, Font P, Lopez-Medina C, Romero-Gomez M, Rodriguez-Escalera C, Perez-Venegas J, Ruiz-Montesinos MD, Dominguez C, Romero-Barco C, Fernandez-Nebro A, Mena-Vazquez N, Marenco JL, Uceda-Montañez J, MD Toledo-Coello, Aguirre MA, Escudero-Contreras A, Collantes-Estevez E, Lopez-Pedrera C
Frontiers in Immunology. 2021 Mar 23. doi: 10.3389/fimmu.2021.631662
- Molecular Changes in the Adipose Tissue Induced by Rheumatoid Arthritis: Effects of Disease-Modifying Anti-Rheumatic Drugs.
Arias de la Rosa I, Escudero-Contreras A, Ruiz-Ponce M, Román-Rodríguez C, Pérez-Sánchez C, Ábalos-Aguilera MDC, Ortega-Castro R, Alcaide J, Murri M, Font P, Calvo-Gutiérrez J, Luque-Tevar M, Patiño-Trives AM, Guzmán-Ruiz R, Malagón MDM, Tinahones FJ, Collantes-Estévez E, López-Pedrera C, Barbarroja N
Frontiers in Immunology. 2021 Oct 13. doi: 10.3389/fimmu.2021.744022
- Prevalence and Associated Factors of Low Bone Mineral Density in the Femoral Neck and Total Hip in Axial Spondyloarthritis: Data from the CASTRO Cohort.
Bautista-Aguilar L, López-Medina C, Ladehesa-Pineda L, Ábalos-Aguilera MDC, Ruiz-Vilchez D, Garrido-Castro JL, Gómez-García I, Puche-Larrubia MÁ, Salmoral-Chamizo A, Collantes-Estévez E, Escudero-Contreras A, Font-Ugalde P
Journal of Clinical Medicine. 2021 Jun 17. doi: 10.3390/jcm10122664
- Splicing machinery is impaired in rheumatoid arthritis, associated with disease activity and modulated by anti-TNF therapy.
Ibáñez-Costa A, Perez-Sanchez C, Patiño-Trives AM, Luque-Tevar M, Font P, Arias de la Rosa I, Roman-Rodriguez C, Abalos-Aguilera MC, Conde C, Gonzalez A, Pedraza-Arevalo S, Del Rio-Moreno M, Blazquez-Encinas R, Segui P, Calvo J, Ortega Castro R, Escudero-Contreras A, Barbarroja N, Aguirre MA, Castaño-Fuentes JP, Luque RM, Collantes-Estevez E, Lopez-Pedrera C
Annals of the Rheumatic Diseases. 2021 Oct 8. doi: 10.1136/annrheumdis-2021-220308
- Validation of GWAS-Identified Variants for Anti-TNF Drug Response in Rheumatoid Arthritis: A Meta-Analysis of Two Large Cohorts.
Sánchez-Maldonado JM, Cáliz R, López-Nevot MÁ, Cabrera-Serrano AJ, Moñiz-Díez A, Canhão H, Ter Horst R, Quartuccio L, Sorensen SB, Glintborg B, Hetland ML, Filipescu I, Pérez-Pampin E, Conesa-Zamora P, Swierkot J, den Broeder AA, De Vita S, Petersen ERB, Li Y, Ferrer MA, Escudero A, Netea MG, Coenen MJH, Andersen V, Fonseca JE, Jurado M, Bogunia-Kubik K, Collantes E, Sainz J
Frontiers in Immunology. 2021 Oct 27. doi: 10.3389/fimmu.2021.672255
- Individual-level and country-level socio-economic factors and health outcomes in spondyloarthritis: analysis of the ASAS-perSpA study.
Capelusnik D, Zhao SS, Boonen A, Ziade N, Lopez-Medina C, Dougados M, Nikiphorou E, Ramiro S
Rheumatology. 2021 Aug 13. doi: 10.1093/rheumatology/keab638
- Age at onset in axial spondyloarthritis around the world: data from the Assessment in SpondyloArthritis international Society Peripheral Involvement in Spondyloarthritis study.
Boel A, López-Medina C, van der Heijde DMFM, van Gaalen FA
Rheumatology. 2021 Apr 14. doi: 10.1093/rheumatology/keab544
- Myo-Spain: Spanish Registry of patients with idiopathic inflammatory myopathy. Methodology.
Cobo-Ibáñez T, Sánchez-Piedra C, Nuño-Nuño L, Castellví I, Carrión-Barberà I, Romero-Bueno F, Narváez J, Trallero-Araguás E, Tomero E, Ruiz-Lucea ME, Larena C, Carrasco Cubero C, Jovaní V, Barbadillo C, Sivera F, Belzunegui J, Pérez Gómez A, Gómez Gómez A, Delgado-Frías E, Pego-Reigosa JM, Joven B, Ibáñez M, Martínez-González O, Ruiz-Román A, Camins J, Ortega-Castro R, Trenor Larra P, Rodríguez López M, Freire M, Alcocer P, Holgado S, Rúa-Figueroa I, Lozano N, Martínez-Barrio J
Reumatología Clínica. 2021 Apr 15. doi: 10.1016/j.reuma.2021.01.007
2020
- Similarities and differences between non-radiographic and radiographic axial spondyloarthritis: The patient perspective from the Spanish atlas.
Garrido-Cumbrera M, Gratacos J, Collantes-Estevez E, Zarco P, Sastre C, Sanz-Gómez S, Navarro-Compán V
Reumatología Clínica. 2020 Dec 3. doi: 10.1016/j.reuma.2020.10.008
- Antiphospholipid Antibody Profile Stability Over Time: Prospective Results From the APS ACTION Clinical Database and Repository.
Gkrouzman E, Sevim E, Finik J, Andrade D, Pengo V, Sciascia S, Tektonidou MG, Ugarte A, Chighizola CB, Belmont HM, Lopez-Pedrera C, Ji L, Fortin P, Efthymiou M, de Jesus GR, Branch DW, Nalli C, Petri M, Rodriguez E, Cervera R, Knight JS, Atsumi T, Willis R, Bertolaccini ML, Cohen H, Rand J, Erkan D, APS ACTION+
Journal of Rheumatology. 2020 Sep 1. doi: 10.3899/jrheum.200513
- Axial and peripheral spondyloarthritis: does psoriasis influence the clinical expression and disease burden? Data from REGISPONSER registry.
López-Medina C, Ortega-Castro R, Castro-Villegas MC , Font-Ugalde P , Puche-Larrubia MA, Gómez-García I , Arias-de la Rosa I, Barbarroja N, Schiotis R , Collantes-Estévez E
Rheumatology. 2020 Aug 28. doi: 10.1093/rheumatology/keaa398
- Characterization of Antiphospholipid Syndrome Atherothrombotic Risk by Unsupervised Integrated Transcriptomic Analyses.
Pérez-Sánchez L, Patiño-Trives AM, Aguirre-Zamorano MÁ, Luque-Tévar M, Ábalos-Aguilera MC, Arias-de la Rosa I, Seguí P, Velasco-Gimena F, Barbarroja N, Escudero-Contreras A, Collantes-Estévez E, Pérez-Sánchez C, López-Pedrera C
Arteriosclerosis, Thrombosis and Vascular Biology. 2020 Dec 24. doi: 10.1161/ATVBAHA.120.315346
- Surface Electromyography of the Longissimus and Gluteus Medius Muscles in Greyhounds Walking and Trotting on Ground Flat, Up, and Downhill.
Miró F, Galisteo AM, Garrido-Castro JL, Vivo J
Animals. 2020 Jun 3. doi: 10.3390/ani10060968
- Standardization procedure for flow cytometry data harmonization in prospective multicenterstudies.
Le Lann L, Jouve PE, Alarcón-Riquelme M, Jamin C, Pers JO; PRECISESADS FlowCytometry Study Group; PRECISESADS Clinical Consortium
Scientific Reports. 2020 Jul 14. doi: 10.1038/s41598-020-68468-3
- Prognostic factors on mortality in patients admitted to hospital with heart failure.
M Valdivia-Marchal, J L Zambrana-Luque, E Girela-López, P Font-Ugalde, M C Salcedo-Sánchez, J L Zambrana-García
Anales del Sistema Sanitario de Navarra. 2020 Apr 20. doi: 10.23938/ASSN.0753
- Postprandial Apolipoprotein B48 is Associated with Subclinical Atherosclerosis in Patients with Rheumatoid Arthritis.
Mena-Vázquez N, Rojas-Gimenez M, Jimenez Nuñez FG, Manrique-Arija S, Rioja J, Ruiz-Limón P, Ureña I, Castro-Cabezas M, Valdivielso P, Fernández-Nebro A
Journal of Clinical Medicine. 2020 Aug. doi: 10.3390/jcm9082483
- No radiographic sacroiliitis progression was observed in patients with early spondyloarthritis at 6 years: results of the Esperanza multicentric prospective cohort.
Fernández-Carballido C, Tornero C, Castro-Villegas MC, Galindez E, García-Llorente JF, García-Vivar ML, Joven-Ibáñez B, Juanola X, Urrego-Laurín C, López-Medina C, Almodovar R, Martínez-Alberola N, Ruiz-Jimeno T, de Miguel E
RMD Open. 2020 Sep. doi: 10.1136/rmdopen-2020-001345
- Non-radiographic versus radiographic axSpA: what's in a name?
Michelena X, López-Medina C, Marzo-Ortega H
Rheumatology. 2020 Oct 1. doi: 10.1093/rheumatology/keaa422
- Measuring Spinal Mobility Using an Inertial MeasurementUnit System: A Validation Study in Axial Spondyloarthritis.
Aranda-Valera IC, Cuesta-Vargas A, Garrido-Castro JL, Gardiner PV, López-Medina C, Machado PM, Condell J, Connolly J, Williams JM, Muñoz-Esquivel K,O'Dwyer T, Castro-Villegas MC, González-Navas C, Collantes-Estévez E, On BehalfOf iMaxSpA Study Group - Diagnostics (Basel)
Diagnostics. 2020 Jun. doi: 10.3390/diagnostics10060426
- Long-term Follow-up and Optimization of Infliximab in Refractory Uveitis Due to Behçet Disease: National Study of 103 White Patients.
Martín-Varillas JL, Atienza-Mateo B, Calvo-Rio V, Beltrán E, Sánchez-Bursón J, Adán A, Hernández-Garfella M, Valls-Pascual E, Sellas-Fernández A, Ortego N, Maíz O, Torre I, Fernández-Espartero C, Jovani V, Peiteado D, Díaz Valle D, Aurrecoechea E, Caracuel MA, García-González AJ, Raya Álvarez E, Vegas-Revenga N, Demetrio-Pablo R, Castañeda S, González-Gay MA, Hernández JL, Blanco R; Ricardo Blanco on behalf of the Spanish Collaborative Group of Refractory Behçet’s Disease
The Journal of Rheumatology. 2020 Oct 1. doi: 10.3899/jrheum.200300
- Is the new ASDAS nomenclature in agreement with therapeutic decision making in patients with axial spondyloarthritis?
Garcia-Magallón B, Castro-Villegas C, Rosello-Pardo R, Salvador-Oliván JA, Navarro-Compán V
Seminars in Arthritis and Rheumatism. 2020 Oct. doi: 10.1016/j.semarthrit.2020.07.010
- In utero exposure to Azathioprine in autoimmune disease. Where do we stand?
Belizna C, Meroni PL, Shoenfeld Y, Devreese K, Alijotas-Reig J, Esteve-Valverde E, Chighizola C, Pregnolato F, Cohen H, Fassot C, Mattera PM, Peretti P, Levy A, Bernard L, Saiet M, Lagarce L, Briet M, Rivière M, Pellier I, Gascoin G, Rakotonjanahary J, Borghi MO, Stojanovich L, Djokovic A, Stanisavljevic N, Bromley R, Elefant-Amoura E, Bahi Buisson N, Pindi Sala T, Kelchtermans H, Makatsariya A, Bidsatze V, Khizroeva J, Latino JO, Udry S, Henrion D, Loufrani L, Guihot AL, Muchardt C, Hasan M, Ungeheuer MN, Voswinkel J, Damian L, Pabinger I, Gebhart J, Lopez Pedrera R, Cohen Tervaert JW, Tincani A, Andreoli L
Autoimmunity Reviews. 2020 Sep. doi: 10.1016/j.autrev.2020.102525
- Integrative Analysis Reveals a Molecular Stratification of Systemic Autoimmune Diseases.
Barturen G, Babaei S, Català-Moll F, Martínez-Bueno M, Makowska Z, Martorell-Marugán J, Carmona-Sáez P, Toro-Domínguez D, Carnero-Montoro E, Teruel M, Kerick M, Acosta-Herrera M, Le Lann L, Jamin C, Rodríguez-Ubreva J, García-Gómez A, Kageyama J, Buttgereit A, Hayat S, Mueller J, Lesche R, Hernandez-Fuentes M, Juarez M, Rowley T, White I, Marañón C, Gomes Anjos T, Varela N, Aguilar-Quesada R, Garrancho FJ, López-Berrio A, Rodriguez Maresca M, Navarro-Linares H, Almeida I, Azevedo N, Brandão M, Campar A, Faria R, Farinha F, Marinho A, Neves E, Tavares A, Vasconcelos C, Trombetta E, Montanelli G, Vigone B, Alvarez-Errico D, Li T, Thiagaran D, Blanco Alonso R, Corrales Martínez A, Genre F, López Mejías R, Gonzalez-Gay MA, Remuzgo S, Ubilla Garcia B, Cervera R, Espinosa G, Rodríguez-Pintó I, De Langhe E, Cremer J, Lories R, Belz D, Hunzelmann N, Baerlecken N, Kniesch K, Witte T, Lehner M, Stummvoll G, Zauner M, Aguirre-Zamorano MA, Barbarroja N, Castro-Villegas MC, Collantes-Estevez E, de Ramon E, Díaz Quintero I, Escudero-Contreras A, Fernández Roldán MC, Jiménez Gómez Y, Jiménez Moleón I, Lopez-Pedrera R, Ortega-Castro R, Ortego N, Raya E, Artusi C, Gerosa M, Meroni PL, Schioppo T, De Groof A, Ducreux J, Lauwerys B, Maudoux AL, Cornec D, Devauchelle-Pensec V, Jousse-Joulin S, Jouve PE, Rouvière B, Saraux A, Simon Q, Alvarez M, Chizzolini C, Dufour A, Wynar D, Balog A, Bocskai M, Deák M, Dulic S, Kádár G, Kovács L, Cheng Q, Gerl V, Hiepe F, Khodadadi L, Thiel S, de Rinaldis E, Rao S, Benschop RJ, Chamberlain C, Dow ER, Ioannou Y, Laigle L, Marovac J, Wojcik J, Renaudineau Y, Borghi MO, Frostegård J, Martín J, Beretta L, Ballestar E, McDonald F, Pers JO, Alarcón-Riquelme ME
Arthritis & Rheumatology. 2020 Dec 8. doi: 10.1002/art.41610
- IgM antibodies against malondialdehyde and phosphorylcholine in different systemic rheumatic diseases.
Thiagarajan D, Oparina N, Lundström S, Zubarev R, Sun J; PRECISESADS Clinical Consortium; Alarcon-Riquelme M, Frostegård J
Scientific Reports. 2020 Jul 3. doi: 10.1038/s41598-020-66981-z
- Experts document on methotrexate use in combined therapy with biological or targeted synthetic disease modifying drugs in patients with rheumatoid arthritis.
Tornero-Molina J, Alperi-López M, Castellví I, de Agustín-de Oro JJ, Escudero A, García-Vicuña R, González-Gay MÁ, Hidalgo C, Rubio E, Sanmartí R, Casamira N, Calvo-Alén J
Reumatología Clínica. . doi: 10.1016/j.reuma.2020.08.003
- Effects of Biological Therapies on Molecular Features of Rheumatoid Arthritis.
Lopez-Pedrera C, Barbarroja N, Patiño-Trives AM, Luque-Tévar M, Collantes-Estevez E, Escudero-Contreras A, Pérez-Sánchez C
International Journal of Molecular Sciences. 2020 Nov 28. doi: 10.3390/ijms21239067
- Effectiveness and safety of 12-month certolizumab pegol treatment for axial spondyloarthritis in real-world clinical practice in Europe.
Baraliakos X, Witte T, De Clerck L, Frediani B, Collantes-Estévez E, Katsifis G, VanLunen B, Kleine E, Hoepken B, Bauer L, Goodson N
Rheumatology. 2020 Jun 25. doi: 10.1093/rheumatology/keaa181
- Does Belonging to a Patient Association Is of Help for Patients with Axial Spondyloarthritis? Results from the Atlas Survey.
Garrido-Cumbrera M, Chacón-García J, Navarro-Compán V, Gratacós J, Sanz-Gómez S, Collantes-Estevez E; Atlas working group
Current Rheumatology Reports. 2020 May 14. doi: 10.1007/s11926-020-00897-5
- Disease-modifying antirheumatic drug prescription patterns in adult rheumatoid arthritis patients in routine clinical practice in Spain.
Hernández Cruz B, Ureña Garnica I, Sánchez Parera R, Rubio Romero E, Calvo Gutiérrez J, García Sánchez A, Rodríguez Escalera C, Navarro Sarabia F
European Journal of Rheumatology. 2020 Sep 3. doi: 10.5152/eurjrheum.2020.19053
- Development and feasibility of 4 checklists for the evaluation of comorbidity in patients with rheumatoid arthritis, axial spondyloarthritis and psoriatic arthritis: GECOAI Project.
Castañeda S, González C, Villaverde V, Lajas Petisco C, Carmen Castro M, Jirout F, Obaya JC, Hermosa JC, Suárez C, García S, Rodero M, León L, López Esteban A, Gobbo M, Alcaide L, Torre-Alonso JC
Reumatología Clínica. 2020 Dec 5. doi: 10.1016/j.reuma.2020.09.003
- COVID-19 pandemic: an opportunity to assess the utility of telemedicine in patients with rheumatic diseases.
López-Medina C, Escudero A, Collantes-Estevez E
Annals of the Rheumatic Diseases. 2020 Jun 5. doi: 10.1136/annrheumdis-2020-218008
- Complement component 3 as biomarker of disease activity and cardiometabolic risk factor in rheumatoid arthritis and spondyloarthritis.
Arias de la Rosa I, Font P, Escudero-Contreras A, López-Montilla MD, Pérez-Sánchez C, Ábalos-Aguilera MC, Ladehesa-Pineda L, Ibáñez-Costa A, Torres-Granados C, Jimenez-Gomez Y, Patiño-Trives A, Luque-Tévar M, MC Castro-Villegas, Calvo-Gutiérrez J, Ortega-Castro R, López-Pedrera C, Collantes-Estévez E, Barbarroja N
Therapeutic Advances in Chronic Disease. 2020 Oct 21. doi: 10.1177/2040622320965067
- Comorbid pain in axial spondyloarthritis, including fibromialgia.
López-Medina C, Moltó A
Therapeutic Advances in Musculoskeletal Disease. 2020 Oct. doi: 10.1177/1759720X20966123
- Comorbidity management in spondyloarthritis.
López-Medina C , Molto A
Rheumatic & Musculoskeletal Diseases. 2020 Sep. doi: 10.1136/rmdopen-2019-001135
- Comment on: Development and validation of an alternative ankylosing spondylitis disease activity score when patient global assessment is unavailable.
Aranda-Valera IC, Garrido-Castro JL, Ladehesa L, Vazquez-Mellado J, Zarco P, Juanola X, González-Navas C, Font-Ugalde P, Castro-Villegas MC
Rheumatology. 2020 Nov 28. doi: 10.1093/rheumatology/keaa690
- Cluster analysis for the identification of clinical phenotypes among antiphospholipid antibody-positive patients from the APS ACTION Registry.
Zuily S, Clerc-Urmès I, Bauman C, Andrade D, Sciascia S, Pengo V, Tektonidou MG, Ugarte A, Gerosa M, Belmont HM, Aguirre Zamorano MA, Fortin P, Ji L, Efthymiou M, Cohen H, Ware Branch D, Ramires de Jesus G, Nalli C, Petri M, Rodriguez E, Cervera R, Knight JS, Atsumi T, Willis R, Bertolaccini ML, Vega J, Wahl D, Erkan D; APS ACTION Investigators
Lupus. 2020 Jul 23. doi: 10.1177/0961203320940776
- Clinical manifestations, disease activity and disease burden of radiographic versus non-radiographic axial spondyloarthritis over 5 years of follow-up in the DESIR cohort.
López-Medina C, Molto A, Claudepierre P, Dougados M
Annals of the Rheumatic Diseases. 2020 Feb. doi: 10.1136/annrheumdis-2019-216218
- Circulating microRNAs as potential biomarkers for monitoring the response to in vivo treatment with Rituximab in systemic lupus erythematosus patients.
Cecchi I, Perez-Sanchez C, Sciascia S, Radin M, Arias de la Rosa I, Barbarroja Puerto N, Scudeler L, Perez-Sanchez L, Patiño Trives AM, Aguirre Zamorano MA, Menegatti E, Roccatello D, Lopez-Pedrera C
Autoinmunity Reviews. 2020 Apr. doi: 10.1016/j.autrev.2020.102488
- Characteristics of Patients With Antiphospholipid Antibody Positivity in the APS ACTION International Clinical Database and Repository.
Sevim E, Zisa D, Andrade D, Sciascia S, Pengo V, Tektonidou MG, Ugarte A, Gerosa M, Belmont HM, Aguirre Zamorano MA, Fortin PR, Ji L, Efthymiou M, Cohen H, Branch DW, Ramires de Jesus G, Andreoli L, Petri M, Rodriguez E, Cervera R, Knight JS, Atsumi T, Willis R, Roubey R, Bertolaccini ML, Erkan D, Barbhaiya M; APS ACTION Investigators
Arthritis Care and Research. 2020 Sep 28. doi: 10.1002/acr.24468
- Brodalumab: short-term effectiveness and safety in real clinical practice.
Ruiz-Villaverde R, Galán-Gutierrez M, Armario-Hita JC, Ruiz-Carrascosa JC, Font-Ugalde P
International Journal of Dermatology. 2020 Sep. doi: 10.1111/ijd.14866
- Assessment of the relationship between estimated cardiovascular risk and structural damage in patients with axial spondyloarthritis.
Ladehesa-Pineda ML, Arias de la Rosa I, López Medina C, Castro-Villegas MC, Ábalos-Aguilera MC, Ortega-Castro R , Gómez-García I, Seguí-Azpilcueta P, Jiménez-Gómez Y, Escudero-Contreras A, López Pedrera C, Barbarroja N , Collantes-Estéve< E ; CASTRO Working Group
Therapeutic Advances in Musculoskeletal Disease. 2020 Dec 30. doi: 10.1177/1759720X20982837
- NFKB2 polymorphisms associate with the risk of developing rheumatoid arthritis and response to TNF inhibitors: Results from the REPAIR consortium.
Rodríguez-Ramos A, Escudero A, Sorensen SB, Hetland ML, Ferrer MA, Glintborg B, Filipescu I, Pérez-Pampin E, Conesa-Zamora P, García A, den Broeder A, De Vita S, Hove Jacobsen SE, Collantes E, Quartuccio L, Netea MG, Li Y, Fonseca JE, Jurado M, López-Nevot MÁ, Coenen MJH, Andersen V, Cáliz R, Sainz J
Scientific Reports. 2020 Mar 9. doi: 10.1038/s41598-020-61331-5
- Inutero exposure to Azathioprine in autoimmune disease
Belizna C, Meroni PL, Shoenfeld Y, Devreese K, Alijotas-Reig J, Esteve-Valverde E, Chighizola C, Pregnolato F, Cohen H, Fassot C, Mattera PM, PerettiP, Levy A, Bernard L, Saiet M, Lagarce L, Briet M, Rivière M, Pellier I, GascoinG, Rakotonjanahary J, Borghi MO, Stojanovich L, Djokovic A, Stanisavljevic N,Bromley R, Elefant-Amoura E, Bahi Buisson N, Pindi Sala T, Kelchtermans H,Makatsariya A, Bidsatze V, Khizroeva J, Latino JO, Udry S, Henrion D, LoufraniL, Guihot AL, Muchardt C, Hasan M, Ungeheuer MN, Voswinkel J, Damian L, PabingerI, Gebhart J, Lopez Pedrera R, Cohen Tervaert JW, Tincani A, Andreoli L
Autoimmunity Reviews. 2020 Mar 30. doi: 10.1016/jautrev2020102525
- Contributions of the lupus register of the Spanish Society of Rheumatology (RELESSER) to the knowledge of systemiclupus erythematosus in Spain.
Rúa-Figueroa Fernández de Larrinoa I, Pego-Reigosa JM; en representación delos investigadores del proyecto RELESSER y del grupo EAS-SER; Investigadores delregistro RELESSER en su fase transversal
Reumatología Clínica. 2020 Mar 20. doi: 101016/jreuma202016
- Role of microRNAs in the Development of cardiovascular disease in systemic Autoimmune disorders
Lopez-Pedrera C, Barbarroja N, Patiño-Trives AM, Luque-Tévar M, Torres-Granados C, Aguirre-Zamorano MA, Collantes-Estevez E, Pérez-Sánchez C.
International Journal of Molecular Sciences. 2020 Mar 16. doi: 10.3390/ijms21062012
- COVID- pandemicanopportunity to assess the utility of telemedicine in patients with rheumaticdiseases
López-Medina C, Escudero A, Collantes-Estevez E
Annals of the Rheumatic Diseases. 2020 Jun 5. doi: 10.1136/annrheumdis-2020-218008
- Surface Electromyography ofthe Longissimus and Gluteus Medius Muscles in Greyhounds Walking and Trotting onGround Flat, Up, and Downhill
Miró F, Galisteo AM, Garrido-Castro JL, Vivo J
Animals (Basel). 2020 Jun 3. doi: 10.3390/ani10060968
- Measuring Spinal Mobility Using an Inertial MeasurementUnit System: A Validation Study in Axial Spondyloarthritis
Aranda-Valera IC, Cuesta-Vargas A, Garrido-Castro JL, Gardiner PV, López-Medina C, Machado PM, Condell J, Connolly J, Williams JM, Muñoz-Esquivel K,O'Dwyer T, Castro-Villegas MC, González-Navas C, Collantes-Estévez E, On BehalfOf iMaxSpA Study Group
Diagnostics (Basel). 2020 Jun 24. doi: 10.3390/diagnostics10060426
- Genome-wide whole blood transcriptome profiling in a large European cohort of systemic sclerosis patients.
Beretta L, Barturen G, Vigone B, Bellocchi C, Hunzelmann N, De Langhe E, Cervera R, Gerosa M, Kovács L, Ortega Castro R, Almeida I, Cornec D, Chizzolini C, Pers JO, Makowska Z, Lesche R, Kerick M, Alarcón-Riquelme ME, Martin J; PRECISESADS SSc substudy group; PRECISESADS Flow Cytometry study group
Annals of the Rheumatic Diseases. 2020 Jun 19. doi: 10.1136/annrheumdis-2020-217116
- Correction to: Influence of HLA-B27 on the Ankylosing Spondylitis phenotype: results from the REGISPONSER database.
Arévalo M, Masmitjà JG, Moreno M, Calvet J, Orellana C, Ruiz D, Castro C, Carreto P, Larrosa M, Collantes E, Font P; REGISPONSER group.
Arthritis Research & Therapy. 2020 Jun 11. doi: 10.1186/s13075-020-02237-5.
- Hip and shoulder involvement and their management in axial spondyloarthritis: a current review.
Clementina López-Medina, M. Carmen Castro-Villegas, and Eduardo Collantes-Estévez.
Curr Rheumatol Rep. 2020 Jul 23. doi: 10.1007/s11926-020-00930-7
- Standardizationprocedure for flow cytometry data harmonization in prospective multicenterstudies
Le Lann L, Jouve PE, Alarcón-Riquelme M, Jamin C, Pers JO; PRECISESADS FlowCytometry Study Group; PRECISESADS Clinical Consortium
Scientific Reports. 2020 Jul 14. doi: 10.1038/s41598-020-68468-3
- Impaired microRNA processing in neutrophils from rheumatoid arthritis patients confers their pathogenic profile. Modulation by biological therapies.
Arias de la Rosa I, Perez-Sanchez C, Ruiz-Limon P, Patiño-Trives A, Torres-Granados C, Jimenez-Gomez Y, Abalos-Aguilera MDC, Cecchi I, Ortega R, Caracuel MA, Calvo-Gutierrez J, Escudero-Contreras A, Collantes-Estevez E, Lopez-Pedrera C, Barbarroja N.
Haematologica. 2020 Jan 2020. doi: 10.3324/haematol.2018.205047
- A cross-disease meta-GWAS identifies four newsusceptibility loci shared between systemic sclerosis and Crohn's disease
González-Serna D, Ochoa E, López-Isac E, Julià A, Degenhardt F, Ortego-Centeno N, Radstake TRDJ, Franke A, Marsal S, Mayes MD, Martín J, Márquez A;Scleroderma Genetic Consortium
Scientific Reports. 2020 Feb 5. doi: 10.1038/s41598-020-58741-w
- Concurrent Validity and Reliability of an Inertial Measurement Unit for the Assessment ofCraniocervical Range of Motion in Subjects with Cerebral Palsy
Carmona-Pérez C, Garrido-Castro JL, Torres Vidal F, Alcaraz-Clariana S,García-Luque L, Alburquerque-Sendín F, Rodrigues-de-Souza DP
Diagnostics (Basel). 2020 Feb 1. doi: 10.3390/diagnostics10020080
- Thermography in systemic sclerosis patients and other rheumatic diseases: Diagnosis, disease activity assessment, and therapeutic monitoring.
Sciascia S, Cecchi I, Massara C, Rossi D, Radin M, Ladehesa PL, Guiñazu F, Rubini E, Foddai SG, Alba P, Escudero A, Menegatti E, Roccatello D.
Autoimmunity Reviews. 2020 Feb. doi: 10.1016/j.autrev.2019.102449
- Arthroscopic repair of partial-thickness articular surface rotator cuff tears: single-rowtranstendon technique versus double-row suture bridge (transosseous equivalent)fixation: results from a prospective randomized study
Zafra M, Uceda P, Muñoz-Luna F, Muñoz-López RC, Font P
ARCHIVES OF ORTHOPAEDIC AND TRAUMA SURGERY. 2020 Aug. doi: 10.1007/s00402-020-03387-6
- Role of HLA-B27 in the comorbidities observedin Axial Spondyloarthritis: Data from COMOSPA
Arévalo M, López-Medina C, Moreno Martinez-Losa M, Moltó A, Font P,Collantes-Estevez E, Gratacós J
Joint Bone Spine. 2020 Apr 3. doi: 10.1016/jjbspin2020312
- Expansion of Rare and Harmful Lineages is Associated with Established Rheumatoid Arthritis.
Mena-Vázquez N*, Ruiz-Limón P*, Moreno-Indias I, Manrique-Arija S, Tinahones FJ, Fernández-Nebro A.
Journal of clinical medicine. 2020 Apr 7. doi: 10.3390/jcm9041044
- Validity and reliability of a sensor-basedelectronic spinal mobility index for axial spondyloarthritis
Gardiner PV, Small D, Muñoz-Esquivel K, Condell J, Cuesta-Vargas A, WilliamsJ, Machado PM, Garrido-Castro JL
Rheumatology. 2020 Apr 28. doi: 10.1093/rheumatology/keaa122
- Enhanced NETosis generation in radiographic axial spondyloarthritis: utility as biomarker for disease activity and anti-TNFa therapy effectiveness
Patricia Ruiz-Limon*, Maria Lourdes Ladehesa-Pineda*, Maria del Carmen Castro-Villegas, Maria del Carmen Abalos-Aguilera, Clementina Lopez-Medina, Chary Lopez-Pedrera, Nuria Barbarroja, Daniel Espejo-Peralbo, Jose Antonio Gonzalez-Reyes, Jose Manuel Villalba, Carlos Perez-Sanchez, Alejandro Escudero-Contreras, Eduardo Collantes-Estevez, Pilar Font-Ugalde* and Yolanda Jimenez-Gomez*
Journal of Biomedical Science. 2020 Apr 17. doi: 10.1186/s12929-020-00634-1
- Circulating microRNAs as potential biomarkers for monitoring the response to in vivo treatment with Rituximab in systemic lupus erythematosus patients.
Cecchi I, Perez-Sanchez C, Sciascia S, Radin M, Arias de la Rosa I, Barbarroja Puerto N, Scudeler L, Perez-Sanchez L, Patiño Trives AM, Aguirre Zamorano MA, Menegatti E, Roccatello D, Lopez-Pedrera C.
Autoimmunity Reviews. 2020 Apr. doi: 10.1016/j.autrev.2020.102488
- Subclinical cardiovascular risk signs in adults with juvenile idiopathic arthritis in sustained remission
Inmaculada Concepción Aranda-Valera† , Iván Arias de la Rosa† , Rosa Roldán-Molina, María del Carmen Ábalos-Aguilera, Carmen Torres-Granados, Alejandra Patiño-Trives, María Luque-Tevar, Alejandro Ibáñez-Costa, Rocío Guzmán-Ruiz, María del Mar Malagón, Alejandro Escudero-Contreras, Chary López-Pedrera, Eduardo Collantes-Estévez† and Nuria Barbarroja
Pediatric Rheumatology. 2020. doi: 10.1186/s12969-020-00448-3
2019
- Assessment of the Adherence to Disease-Modifying Drugs in Patients With Chronic Inflammatory Rheumatic Diseases: Results of a Survey of 1594 Patients
López-Medina C, Moltó A, Gérald F, Dubremetz M, Grange L, Thibaud G, Charles B, Lafarge D, Beauvais C, Gossec L
Joint Bone Spine. 2019 Oct. doi: 10.1016/j.jbspin.2019.01.023
- Characteristics and burden of disease in patients with radiographic and non-radiographic axial Spondyloarthritis: a comparison by systematic literature review and meta-analysis
López-Medina C, Ramiro S, van der Heijde D, Sieper J, Dougados M, Molto A.
RMD Open. 2019 Nov 21. doi: 10.1136/rmdopen-2019-001108
- Pregnancy outcomes in mixed connective tissue disease: a multicentre study.
Radin M, Schreiber K, Cuadrado MJ, Cecchi I, Andreoli L, Franceschini F, Caleiro T, Andrade D, Gibbone E, Khamashta M, Buyon J, Izmirly P, Aguirre MA, Benedetto C, Roccatello D, Marozio L, Sciascia S
Rheumatology. 2019 Nov 1. doi: 10.1093/rheumatology/kez141
- Comparative Study of Infliximab Versus Adalimumab in Refractory Uveitis due to Behçet's Disease: National Multicenter Study of 177 Cases.
Atienza-Mateo B, Martin-Varillas JL, Calvo-Rio V, Demetrio-Pablo R, Beltran E, Sanchez-Burson J, Mesquida M, Adan A, Hernandez MV, Hernandez-Garfella M, Valls-Pascual E, Martinez-Costa L, Sellas-Fernandez A, Cordero-Coma M, Diaz-Llopis M, Gallego R, Garcia-Serrano JL, Ortego-Centeno N, Herreras JM, Fonollosa A, Garcia-Aparicio AM, Maiz-Alonso O, Blanco A, Torre-Salaberri I, Fernandez-Espartero C, Jovani V, Peiteado D, Pato E, Cruz J, Fernandez-Cid C, Aurrecoechea E, Garcia-Arias M, Castaneda S, Caracuel-Ruiz MA, Montilla-Morales CA, Atanes-Sandoval A, Francisco F, Insua S, Gonzalez-Suarez S, Sanchez-Andrade A, Gamero F, Ferrando LFL, Romero-Bueno F, Garcia-Gonzalez AJ, Gonzalez RA, Muro EM, Carrasco-Cubero C, Olive A, Prior A, Vazquez J, Ruiz-Moreno O, Jimenez-Zorzo F, Manero J, Fernandez SM, Fernandez-Carballido C, Rubio-Romero E, Pages FA, de Miera FJTS, Martinez MG, Diaz-Valle D, Longo FJL, Nolla JM, Alvarez ER, Martinez MR, Gonzalez-Lopez JJ, Rodriguez-Cundin P, Hernandez JL, Gonzalez-Gay MA, Blanco R.
Arthritis & Rheumatology. 2019 Dec. doi: 10.1002/art.41026
- Prevalence of Antiphospholipid Antibodies Negativisation in Patients with Antiphospholipid Syndrome: A Long-Term Follow-Up Multicentre Study
Radin M, Schreiber K, Sciascia S, Roccatello D, Cecchi I, Zamorano MAA, Cuadrado MJ
Thrombosis and haemostasis. 2019 Dec. doi: 10.1055/s-0039-1696687
- LAUDES Study: impact of digital ulcers on hand functional limitation, work productivity and daily activities, in systemic sclerosis patients.
Castellví I, Eguiluz S, Escudero-Contreras A, Ríos JJ, Calvo-Alén J, Callejas-Rubio JL, De la Puente C, Simeón CP, Narváez FJ, Espinosa G, Carreira PE, Rubio-Rivas M, Alegre JJ, Guillén-Del-Castillo A, Román-Ivorra JA, Fonollosa V; LAUDES Study Group.
Rheumatology International. 2019 Nov. doi: 10.1007/s00296-019-04436-z
- Cardiovascular risk factors in psoriatic disease: psoriasis versus psoriatic arthritis.
Barbarroja N, Arias-de la Rosa I, López-Medina C, Camacho-Sánchez MDR, Gómez-García I, Vélez-García AJ, Escudero-Contreras A, López-Pedrera C, López-Montilla MD, Collantes-Estévez E.
Therapeutic Advances in Musculoskeletal Disease. 2019 Oct 16. doi: doi.org/10.1177/1759720X19880742
- Steroid hormone-related polymorphisms associate with the development of bone erosions in rheumatoid arthritis and help to predict disease progression: Results from the REPAIR consortium.
Sánchez-Maldonado JM, Cáliz R, Canet L, Horst RT, Bakker O, den Broeder AA, Martínez-Bueno M, Canhão H, Rodríguez-Ramos A, Lupiañez CB, Soto-Pino MJ, García A, Pérez-Pampin E, González-Utrilla A, Escudero A, Segura-Catena J, Netea-Maier RT, Ferrer MÁ, Collantes-Estevez E, López Nevot MÁ, Li Y, Jurado M, Fonseca JE, Netea MG, Coenen MJH, Sainz J.
Scientific Reports. 2019 Oct 15. doi: 10.1038/s41598-019-51255-0
- Translational validation of the Global Antiphospholipid Syndrome Score in patients with thrombotic APS.
Arias de la Rosa I, Radin M, Cecchi I, Rubini E, Pérez-Sánchez C, Aguirre MÁ, Menegatti E, Barbarroja N, Collantes E, Sciascia S, Roccatello D, López Pedrera C.
Rheumatology (Oxford). 2019 Oct 1. doi: 10.1093/rheumatology/kez166
- Reducing or Maintaining the Dose of Subcutaneous Tocilizumab in Patients With Rheumatoid Arthritis in Clinical Remission: A Randomized, Open-Label Trial.
Sanmarti R, Veale DJ, Martin-Mola E, Escudero-Contreras A, González C, Ercole L, Alonso R, Fonseca JE; ToSpace Study Group.
Arthritis & Rheumatology. 2019 Oct. doi: 10.1002/art.40905
- Early restoration of immune and vascular phenotypes in systemic lupus erythematosus and rheumatoid arthritis patients after B cell depletion.
Pérez-Sánchez C, Cecchi I, Barbarroja N, Patiño-Trives AM, Luque-Tévar M, Pérez-Sánchez L, Ibáñez-Costa A, Arias de la Rosa I, Ortega R, Escudero A, Castro MC, Radin M, Roccatello D, Sciascia S, Aguirre MÁ, Collantes E, López-Pedrera C; BIOSAR Study Group.
Journal of Cellular and Molecular Medicin. 2019 Sep. doi: 10.1111/jcmm.14517
- Molecular Characterization of Monocyte Subsets Reveals Specific and Distinctive Molecular Signatures Associated With Cardiovascular Disease in Rheumatoid Arthritis.
Ruiz-Limon P, Ortega-Castro R, Barbarroja N, Perez-Sanchez C, Jamin C, Patiño-Trives AM, Luque-Tevar M, Ibáñez-Costa A, Perez-Sanchez L, de la Rosa IA, Abalos-Aguilera M, Jimenez-Gomez Y, Calvo-Gutierrez J, Font P, Escudero-Contreras A, Alarcon-Riquelme ME, Collantes-Estevez E, López-Pedrera C; PRECISESADS Clinical Consortium and Flow Cytometry Study Group.
Frontiers in Immunology. 2019 May 21. doi: 10.3389/fimmu.2019.01111
- The adjusted global antiphospholipid syndrome score (aGAPSS) and the risk of recurrent thrombosis: Results from the APS ACTION cohort.
Radin M, Sciascia S, Erkan D, Pengo V, Tektonidou MG, Ugarte A, Meroni P, Ji L, Belmont HM, Cohen H, Ramires de Jesús G, Branch DW, Fortin PR, Andreoli L, Petri M, Rodriguez E, Rodriguez-Pinto I, Knight JS, Atsumi T, Willis R, Gonzalez E, Lopez-Pedrera R, Rossi Gandara AP, Borges Gualhardo Vendramini M, Banzato A, Sevim E, Barbhaiya M, Efthymiou M, Mackie I, Bertolaccini ML, Andrade D; APS ACTION.
Seminars in Arthritis and Rheumatism. 2019 May 2. doi: 10.1016/j.semarthrit.2019.04.009
- Identification of a 3′‐Untranslated Genetic Variant of RARB Associated With Carotid Intima‐Media Thickness in Rheumatoid Arthritis: A Genome‐Wide Association Study.
López-Mejías R, Carmona FD, Genre F, Remuzgo-Martínez S, González-Juanatey C, Corrales A, Vicente EF, Pulito-Cueto V, Miranda-Filloy JA, Ramírez Huaranga MA, Blanco R, Robustillo-Villarino M, Rodríguez-Carrio J, Alperi-López M, Alegre-Sancho JJ, Mijares V, Lera-Gómez L, Pérez-Pampín E, González A, Ortega-Castro R, López-Pedrera C, García Vivar ML, Gómez-Arango C, Raya E, Narvaez J, Balsa A, López-Longo FJ, Carreira P, González-Álvaro I, Rodríguez-Rodríguez L, Fernández-Gutiérrez B, Ferraz-Amaro I, Gualillo O, Castañeda S, Martín J, Llorca J, González-Gay MA.
Arthritis & Rheumatology. 2019 March. doi: 10.1002/art.40734
- New Biomarkers for Atherothrombosis in Antiphospholipid Syndrome: Genomics and Epigenetics Approaches.
Lopez-Pedrera C, Barbarroja N, Patiño-Trives AM, Collantes E, Aguirre MA, Perez-Sanchez C.
Frontiers in Immunology. 2019 Apr 16. doi: 10.3389/fimmu.2019.00764
- Factors associated with long-term retention of treatment with golimumab in a real-world setting: an analysis of the Spanish BIOBADASER registry.
Hernandez MV, Sanchez-Piedra C, Garcia-Magallon B, Cuende E, Manero J, Campos-Fernandez C, Martin-Domenech R, Del Pino-Montes J, Manrique S, Castro-Villegas MC, Ruiz-Montesinos D, Sanchez-Alonso F, Diaz-Gonzalez F, Cea-Calvo L, Gómez-Reino JJ; BIOBADASER Study Group.
Rheumatology International. 2019 Mar. doi: 10.1007/s00296-018-4177-z
- Novel Approach to Estimate Osteoarthritis Progression: Use of the Reliable Change Index in the Evaluation of Joint Space Loss.
Parsons CM, Judge A, Leyland K, Bruyère O, Petit Dop F, Chapurlat R, Reginster JY, Edwards MH, Dennison EM, Cooper C, Inskip H; SEKOIA Study Group.Arthritis Care & Research. 2019 Feb. doi: 10.1002/acr.23596
- Polymorphisms at phase I-metabolizing enzyme and hormone receptor loci influence the response to anti-TNF therapy in rheumatoid arthritis patients.
Pharmacogenomics Journal. 2019 Feb. doi: 10.1038/s41397-019-0084-2
- Low incidence of vertebral fractures in early spondyloarthritis: 5-year prospective data of the DESIR cohort.
Sahuguet J, Fechtenbaum J, Molto A, Etcheto A, López-Medina C, Richette P, Dougados M, Roux C, Briot K
Annals of the Rheumatic Diseases. 2019 Jan. doi: 10.1136/annrheumdis-2018-213922
2018
- Neutrophils: Novel key players in Rheumatoid Arthritis. Current and future therapeutic targets.
Cecchi I, Arias de la Rosa I, Menegatti E, Roccatello D, Collantes-Estevez E, Lopez-Pedrera C, Barbarroja N.
Autoinmmunity Review. 2018 Nov. doi: 10.1016/j.autrev.2018.06.006
- Atlas of Axial Spondyloarthritis in Spain 2017: Study Design and Population.
Garrido-Cumbrera M, Navarro-Compán V, Zarco P, Collantes-Estévez E, Gálvez-Ruiz D, Braçe O, Chacón García J, Blanch Mur C, Costa Ferrer A, Hidalgo Vega A, Plazuelo Ramos P, Gratacós Masmitja J.
Reumatología Clínica. 2018 Oct 3. doi: 10.1016/j.reuma.2018.08.003
- Influence of HLA-B27 on the Ankylosing Spondylitis phenotype: results from the REGISPONSER database.
Arévalo M, Gratacós Masmitjà J, Moreno M, Calvet J, Orellana C, Ruiz D, Castro C, Carreto P, Larrosa M, Collantes E, Font P; REGISPONSER group.
Arthritis Research and Therapy. 2018 Oct 3. doi: 10.1186/s13075-018-1724-7
- Clinical whole-genome sequencing from routine formalin-fixed, paraffin-embedded specimens: pilot study for the 100,000 Genomes Project.
Robbe P, Popitsch N, Knight SJL, Antoniou P, Becq J, He M, Kanapin A, Samsonova A, Vavoulis DV, Ross MT, Kingsbury Z, Cabes M, Ramos SDC, Page S, Dreau H, Ridout K, Jones LJ, Tuff-Lacey A, Henderson S, Mason J, Buffa FM, Verrill C, Maldonado-Perez D, Roxanis I, Collantes E, Browning L, Dhar S, Damato S, Davies S, Caulfield M, Bentley DR, Taylor JC, Turnbull C, Schuh A; 00,000 Genomes Project.
Genetic Medicine. 2018 Oct. doi: 10.1038/gim.2017.241
- Assessment of SpondyloArthritis International Society (ASAS) Consensus on Spanish Nomenclature for Spondyloarthritis.
Navarro-Compán V, Otón T, Loza E, Almodóvar R, Ariza-Ariza R, Bautista-Molano W, Burgos-Vargas R, Collantes-Estévez E, de Miguel E, González-Fernández C, Gratacós J, Ibáñez S, Juanola X, Maldonado-Cocco J, Moltó A, Mulero J, Pacheco-Tena C, Ramos-Remus C, Sanz-Sanz J, Valle-Oñate R, Zarco P, Marzo-Ortega H.
Reumatología Clínica. 2018 Sep 4. doi: 10.1016/j.reuma.2018.07.014
- Update on the epidemiology, risk factors, and disease outcomes of axial spondyloarthritis.
López-Medina C, Moltó A.
Best Pract Res Clin Rheumatol. 2018 Apr. doi: 10.1016/j.berh.2018.10.006
- Variability in the prescription of biological drugs in rheumatoid arthritis in Spain: a multilevel analysis.
López-Longo FJ, Seoane-Mato D, Martín-Martínez MA, Sánchez-Alonso F; emAR II Group
Rheumatology International. 2018 Apr. doi: 10.1007/s00296-018-3933-4.
- VCE-004.3, a cannabidiol aminoquinone derivative, prevents bleomycin-induced skin fibrosis and inflammation trough PPARγ- and CB2 -dependent pathways.
Del Rio C, Cantarero I, Palomares B, Gómez-Cañas M, Fernández-Ruiz J, Pavicic C, García-Martín A, Luz Bellido M, Ortega-Castro R, Pérez-Sánchez C, López-Pedrera C, Appendino G, Calzado MA, Muñoz E.
Br J Pharmacol. 2018 Jul 22. doi: 10.1111/bph.14450.
- High Reproducibility of an Automated Measurement of Mobility for Patients with Axial Spondyloarthritis.
Garrido-Castro JL, Curbelo R, Mazzucchelli R, Domínguez-González ME, Gonzalez-Navas C, Flores Robles BJ, Zarco P, Mulero J, Cea-Calvo L, Arteaga MJ, Font-Ugalde P, Carmona L, Collantes-Estevez E.
J Rheumatol. 2018 Jun 15. pii: jrheum.170941. doi: 10.3899/jrheum.170941
- Evaluation of quality of life in patients with axial spondyloarthritis and its association with disease activity, functionality, mobility, and structural damage.
López-Medina C, Garrido-Castro JL, Castro-Jiménez J, González-Navas C, Calvo-Gutiérrez J, Castro-Villegas MC, Ortega-Castro R, Escudero-Contreras A, Font-Ugalde P, Collantes-Estévez E.
Clin Rheumatol. 2018 Jun;37(6):1581-1588. doi: 10.1007/s10067-018-4112-4. Epub 2018 Apr 24.
- Adherence to recommendations for the use of anti-tumour necrosis factor and its impact over 5 years of follow-up in axial spondyloarthritis.
López-Medina C, Dougados M, Collantes-Estévez E, Moltó A.
Rheumatology (Oxford). 2018 May 1;57(5):880-890. doi: 10.1093/rheumatology/kex514.
- An Assessment in SpondyloArthritis International Society (ASAS)-endorsed definition of clinically important worsening in axial spondyloarthritis based on ASDAS.
Molto A, Gossec L, Meghnathi B, Landewé RBM, van der Heijde D, Atagunduz P, Elzorkany BK, Akkoc N, Kiltz U, Gu J, Wei JCC, Dougados M; ASAS-FLARE study group.
Ann Rheum Dis. 2018 Jan;77(1):124-127. doi: 10.1136/annrheumdis-2017-212178.
- Circulating microRNAs as biomarkers of disease and typification of the atherothrombotic status in Antiphospholipid Syndrome.
Perez-Sánchez C, Arias-de la Rosa I, Aguirre MÁ, Luque-Tévar M, Ruiz-Limón P, Barbarroja N, Jiménez-Gómez Y, Ábalos-Aguilera MC, Collantes-Estévez E, Segui P, Velasco F, Herranz MT, Lozano-Herrero J, Hernandez-Vidal MJ, Martínez C, González-Conejero R, Radin M, Sciascia S, Cecchi I, Cuadrado MJ, López-Pedrera C.
Haematologica. 2018 Mar 15. pii: haematol.2017.184416. doi: 10.3324/haematol.2017.184416
- Defective glucose and lipid metabolism in rheumatoid arthritis is determined by chronic inflammation in metabolic tissues.
Arias de la Rosa I, Escudero-Contreras A, Rodríguez-Cuenca S, Ruiz-Ponce M, Jiménez-Gómez Y, Ruiz-Limón P, Pérez-Sánchez C, Ábalos-Aguilera MC, Cecchi I, Ortega R, Calvo J, Guzmán-Ruiz R, Malagón MM, Collantes-Estevez E, Vidal-Puig A, López-Pedrera C, Barbarroja N.
J Intern Med. 2018 Mar 12. doi: 10.1111/joim.12743.
- Circulating microRNAs as potential biomarkers of disease activity and structural damage in ankylosing spondylitis patients.
Perez-Sanchez C, Font-Ugalde P, Ruiz-Limon P, Lopez-Pedrera C, Castro-Villegas MC, Abalos-Aguilera MC, Barbarroja N, Arias-de la Rosa I, Lopez-Montilla MD, Escudero-Contreras A, Lopez-Medina C, Collantes-Estevez E, Jimenez-Gomez Y.
Hum Mol Genet. 2018 Mar 1;27(5):875-890. doi: 10.1093/hmg/ddy008
2017
- Recurrent thrombosis in patients with antiphospholipid antibodies and arterial thrombosis on antithrombotic therapy.
Jackson WG, Oromendia C, Unlu O, Erkan D, DeSancho MT; Antiphospholipid Syndrome Alliance for Clinical Trials and International Networking.
Blood Adv. 2017 Nov 16;1(25):2320-2324. doi: 10.1182/bloodadvances.2017008185. eCollection 2017 Nov 28.
- Clinical utility of the ASDAS index in comparison with BASDAI in patients with ankylosing spondylitis (Axis Study).
Sellas I Fernandez A1, Juanola Roura X2, Alonso Ruiz A3, Rosas J4, Medina Luezas J5, Collantes Estevez E6, Abad Hernández MÁ7, Carrasco Benitez V8, Fisac C9.
Rheumatol Int. 2017 Nov;37(11):1817-1823. doi: 10.1007/s00296-017-3814-2. Epub 2017 Sep 16.
- An MIF Promoter Polymorphism Is Associated with Susceptibility to Pulmonary Arterial Hypertension in Diffuse Cutaneous Systemic Sclerosis.
Bossini-Castillo L, Campillo-Davó D, López-Isac E, Carmona FD, Simeon CP, Carreira P, Callejas-Rubio JL, Castellví I, Fernández-Nebro A, Rodríguez-Rodríguez L, Rubio-Rivas M, García-Hernández FJ, Madroñero AB, Beretta L, Santaniello A, Lunardi C, Airó P, Hoffmann-Vold AM, Kreuter A, Riemekasten G, Witte T, Hunzelmann N, Vonk MC, Voskuyl AE, de Vries-Bouwstra J, Shiels P, Herrick A, Worthington J, Radstake TRDJ, Martin J; Spanish Scleroderma Group.
J Rheumatol. 2017 Oct;44(10):1453-1457
- Antiphospholipid antibodies negativization: time for testing for non-criteria aPL?
Radin M1, Cecchi I1, Pérez-Sánchez C2.
Lupus. 2017 Nov;26(13):1457-1458. doi: 10.1177/0961203317711014. Epub 2017 May 22.
- Ubiquinol Effects on Antiphospholipid Syndrome Prothrombotic Profile: A Randomized, Placebo-Controlled Trial.
Pérez-Sánchez C1, Aguirre MÁ1, Ruiz-Limón P1, Ábalos-Aguilera MC1, Jiménez-Gómez Y1, Arias-de la Rosa I1, Rodriguez-Ariza A1, Fernández-Del Río L1, González-Reyes JA1, Segui P1, Collantes-Estévez E1, Barbarroja N1, Velasco F1, Sciascia S1, Cecchi I1, Cuadrado MJ1, Villalba JM1, López-Pedrera C2.
Arterioscler Thromb Vasc Biol. 2017 Oct;37(10):1923-1932. doi: 10.1161/ATVBAHA.117.309225. Epub 2017 Jul 6.
- Optimization of biological therapy in rheumatoid arthritis patients: outcomes from the CREATE registry after 2 years of follow-up.
Cárdenas MJ1, de la Fuente S2, Castro-Villegas MC3, Romero-Gómez M3, Ruiz-Vílchez D3, Calvo-Gutiérrez J3, Escudero-Contreras A3, Del Prado JR2, Collantes-Estévez E3, Font P3.
Rheumatol Int. 2017 Oct;37(10):1701-1708. doi: 10.1007/s00296-017-3757-7. Epub 2017 Jun 9.
- Recommendations for the prescription of physical exercise for patients with spondyloarthritis.
Flórez García MT1, Carmona L2, Almodóvar R3, Fernández de Las Peñas C4, García Pérez F5, Pérez Manzanero MÁ5, García García JM6, Soriano Segarra L7, Jiménez Díaz JF5, Mendoza Laiz N6, de Miguel Mendieta E8, Torre Alonso JC9, Linares Ferrando LF10, Collantes Estévez E11, Sanz Sanz J12, Zarco Montejo P5.
Reumatol Clin. 2017 Aug 11. pii: S1699-258X(17)30174-2. doi: 10.1016/j.reuma.2017.06.014.
- Mechanisms of atherosclerosis and cardiovascular disease in antiphospholipid syndrome and systemic lupus erythematosus. New therapeutic approaches.
Lopez-Pedrera C1, Aguirre-Zamorano MÁ2, Pérez-Sánchez C2.
Med Clin (Barc). 2017 Aug 22;149(4):160-169. doi: 10.1016/j.medcli.2017.05.003. Epub 2017 Jun 12.
- Identification and management of comorbidity in psoriatic arthritis: evidence- and expert-based recommendations from a multidisciplinary panel from Spain.
Torre-Alonso JC1, Carmona L2, Moreno M3, Galíndez E4, Babío J5, Zarco P6, Linares L7, Collantes-Estevez E8, Barrial MF9, Hermosa JC10, Coto P11, Suárez C12, Almodóvar R6, Luelmo J3, Castañeda S12, Gratacós J3.
Rheumatol Int. 2017 Aug;37(8):1239-1248. doi: 10.1007/s00296-017-3702-9. Epub 2017 Apr 7
- Diagnostic potential of NETosis-derived products for disease activity, atherosclerosis and therapeutic effectiveness in Rheumatoid Arthritis patients.
Pérez-Sánchez C1, Ruiz-Limón P2, Aguirre MA3, Jiménez-Gómez Y2, Arias-de la Rosa I1, Ábalos-Aguilera MC1, Rodriguez-Ariza A1, Castro-Villegas MC4, Ortega-Castro R4, Segui P1, Martinez C5, Gonzalez-Conejero R5, Rodríguez-López S6, Gonzalez-Reyes JA6, Villalba JM6, Collantes-Estévez E3, Escudero A4, Barbarroja N1, López-Pedrera C7.
J Autoimmun. 2017 Aug;82:31-40. doi: 10.1016/j.jaut.2017.04.007. Epub 2017 Apr 29
- Cardiovascular risk factors in patients with spondyloarthritis from Northern European and Mediterranean countries: An ancillary study of the ASAS-COMOSPA project.
López-Medina C1, Jiménez-Gómez Y2, Moltó A3, Schiotis RE4, Marzo-Ortega H5, van Gaalen FA6, Ozgocmen S7, Dougados M3, Calvo-Gutiérrez J2, Castro-Villegas MC2, Collantes-Estévez E2, Font-Ugalde P2; ASAS-COMOSPA task force.
Joint Bone Spine. 2017 Jul 25. pii: S1297-319X(17)30139-2. doi: 10.1016/j.jbspin.2017.07.006
- Genome-wide pathway analysis identifies VEGF pathway association with oral ulceration in systemic lupus erythematosus.
Aterido A1,2, Julià A3, Carreira P4, Blanco R5, López-Longo JJ6, Venegas JJP7, Olivé À8, Andreu JL9, Aguirre-Zamorano MÁ10, Vela P11, Nolla JM12, Marenco-de la Fuente JL13, Zea A14, Pego JM15, Freire M16, Díez E17, López-Lasanta M1, López-Corbeto M1, Palau N1, Tortosa R1, Gelpí JL18, Absher D19, Myers RM19, Fernández-Nebro A20,21, Marsal S1.
Arthritis Res Ther. 2017 Jun 15;19(1):138. doi: 10.1186/s13075-017-1345-6.7
- Diagnostic Value and Validity of Early Spondyloarthritis Features: Results From a National Spanish Cohort.
Joven BE, Navarro-Compán V, Rosas J, Fernandez Dapica P, Zarco P, de Miguel E; Esperanza Working Group.
Arthritis Care Res (Hoboken). 2017 Jun;69(6):938-942. doi: 10.1002/acr.23017. Epub 2017 May 9. PMID: 28129460poprotein(a) concentrations in rheumatoid arthritis on biologic therapy: Results from the CARdiovascular in rheuMAtology study project.
García-Gómez C, Martín-Martínez MA, Castañeda S, Sanchez-Alonso F, Uriarte-Ecenarro M, González-Juanatey C, Romera-Baures M, Santos-Rey J, Pinto-Tasende JA, Quesada-Masachs E, Tornero-Molina J, Martínez-González O, Cobo-Ibáñez T, Chamizo-Carmona E, Manrique-Arija S, Fábregas-Canales D, Díaz-González F, Llorca J, González-Gay MA; CARMA Project Collaborative Group.
J Clin Lipidol. 2017 May - Jun;11(3):749-756.e3. doi: 10.1016/j.jacl.2017.02.018. Epub 2017 Mar 16. PMID: 28476652
- European Randomized Study of Screening for Prostate Cancer Risk Calculator: External Validation, Variability, and Clinical Significance.
Gómez-Gómez E1, Carrasco-Valiente J2, Blanca-Pedregosa A3, Barco-Sánchez B2, Fernandez-Rueda JL4, Molina-Abril H4, Valero-Rosa J2, Font-Ugalde P5, Requena-Tapia MJ2.
Urology. 2017 Apr;102:85-91. doi: 10.1016/j.urology.2016.11.004. Epub 2016 Nov 10
- Recommendations for the Management of Comorbidity in Patients With Axial Spondyloarthritis in Clinical Practice.
González C, Curbelo Rodríguez R, Torre-Alonso JC, Collantes E, Castañeda S, Hernández MV, Urruticoechea-Arana A, Nieto-González JC, García J, Abad MÁ, Ramírez J, Suárez C, Dalmau R, Martín-Arranz MD, León L, Hermosa JC, Obaya JC, Otón T, Carmona L.
Reumatol Clin. 2017 Apr 28. pii: S1699-258X(17)30081-5. doi: 10.1016/j.reuma.2017.03.011. English, Spanish. PMID: 28461161
- Development of a checklist for patients with axial spondyloarthritis and psoriatic arthritis in daily practice: ONLY TOOLS project.
Almodovar R1, Torre Alonso JC2, Batlle E3, Castillo C4, Collantes-Estevez E5, de Miguel E6, González S7, Gratacós J8, Hernández A9, Juanola X10, Linares LF11, Moreno MJ11, Moreno M8, Navarro-Compán V6, Rodríguez Lozano C12, Sanz J13, Sellas A14, Loza E15, Zarco P1; grupo de trabajo ONLY TOOLS.
Reumatol Clin. 2017 Mar 9. pii: S1699-258X(16)30168-1. doi: 10.1016/j.reuma.2016.12.003
- Regulation of TFPIα expression by miR-27a/b-3p in human endothelial cells under normal conditions and in response to androgens
B Arroyo A1, Salloum-Asfar S1, Pérez-Sánchez C2, Teruel-Montoya R1, Navarro S3, García-Barberá N1, Luengo-Gil G1, Roldán V1, Hansen JB4, López-Pedrera C2, Vicente V1, González-Conejero R1, Martínez C1.
Sci Rep. 2017 Feb 27;7:43500. doi: 10.1038/srep43500
- Enhanced depth OCT imaging of the lamina cribrosa for 24 hours.
Naranjo-Bonilla P1, Giménez-Gómez R1, Ríos-Jiménez D1, Varas-Fabra ML1, Muñoz-Villanueva MD2, García-Catalán R1, Font-Ugalde P3, Poblador-Fernández MS4, Lancho-Alonso JL4, Gallardo-Galera JM1.
Int J Ophthalmol. 2017 Feb 18;10(2):306-309. doi: 10.18240/ijo.2017.02.20. eCollection 2017.
- Can we withdraw anticoagulation in patients with antiphospholipid syndrome after seroconvertion?
Sciascia S, Coloma-Bazán E2, Radin M1, Bertolaccini ML3, López-Pedrera C4, Espinosa G2, Meroni PL5, Cervera R2, Cuadrado MJ6.
Autoimmun Rev. 2017 Nov;16(11):1109-1114. doi: 10.1016/j.autrev.2017.09.004
- Disease Activity As a Major Determinant of Quality of Life and Physical Function in Patients With Early Axial Spondyloarthritis.
Fernández-Carballido C, Navarro-Compán V, Castillo-Gallego C, Castro-Villegas MC, Collantes-Estévez E, de Miguel E; Esperanza Study Group.
Arthritis Care Res (Hoboken). 2017 Jan;69(1):150-155. doi: 10.1002/acr.22908.
2016
- Tocilizumab improves the proatherothrombotic profile of rheumatoid arthritis patients modulating endothelial dysfunction, NETosis, and inflammation.
Ruiz-Limón P, Ortega R, Arias de la Rosa I, Abalos-Aguilera MD, Perez-Sanchez C, Jimenez-Gomez Y, Peralbo-Santaella E, Font P, Ruiz-Vilches D, Ferrin G, Collantes-Estevez E, Escudero-Contreras A, López-Pedrera C, Barbarroja N.
Transl Res. 2016 Dec 9. pii: S1931-5244(16)30423-6. doi: 10.1016/j.trsl.2016.12.003.
- Gender differences among patients with primary ankylosing spondylitis and spondylitis associated with psoriasis and inflammatory bowel disease in an iberoamerican spondyloarthritis cohort.
Landi M, Maldonado-Ficco H, Perez-Alamino R, Maldonado-Cocco JA, Citera G, Arturi P, Sampaio-Barros PD, Flores Alvarado DE, Burgos-Vargas R, Santos E, Palleiro D, Gutiérrez MA, Vieyra-Sousa E, Pimentel-Santos F, Paira SO, Berman A, Barrezueta CV, Vazquez-Mellado J, Collantes-Estevez E; RESPONDIA Group. Fundación Reumatológica Argentina “Dr. Osvaldo García Morteo..
Medicine (Baltimore). 2016 Dec;95(51):e5652. doi: 10.1097
- Cost-effectiveness of clinical remission by treat to target strategy in established rheumatoid arthritis: results of the CREATE registry.
Cárdenas M, de la Fuente S, Castro-Villegas MC, Romero-Gómez M, Ruiz-Vílchez D, Calvo-Gutiérrez J, Escudero-Contreras A, Del Prado JR, Collantes-Estévez E, Font P.
Rheumatol Int. 2016 Dec;36(12):1627-1632.
- Oxidative stress in the pathogenesis of atherothrombosis associated with anti-phospholipid syndrome and systemic lupus erythematosus: new therapeutic approaches.
López-Pedrera C, Barbarroja N, Jimenez-Gomez Y, Collantes-Estevez E, Aguirre MA, Cuadrado MJ.
Rheumatology (Oxford). 2016 Dec;55(12):2096-2108. Review.
- Multi-center harmonization of flow cytometers in the context of the European "PRECISESADS" project.
Jamin C, Le Lann L, Alvarez-Errico D, Barbarroja N, Cantaert T, Ducreux J, Dufour AM, Gerl V, Kniesch K, Neves E, Trombetta E, Alarcón-Riquelme M, Marañon C, Pers JO.
Autoimmun Rev. 2016 Nov;15(11):1038-1045. doi: 10.1016/j.autrev.2016.07.034.
- Non-vitamin K antagonist oral anticoagulants and antiphospholipid syndrome.
Sciascia S, Lopez-Pedrera C, Cecchi I, Pecoraro C, Roccatello D, Cuadrado MJ.
Rheumatology (Oxford). 2016 Oct;55(10):1726-35. doi: 10.1093/rheumatology/kev445. Review.
- Upswings in Cheerful Mood and Disease Activity in Patients with Rheumatoid Arthritis.
Delgado-Domínguez CJ, Escudero-Contreras A, Font-Ugalde P, Ruiz-Vilchez D, Collantes-Estévez E, Carretero-Dios H.
Int J Behav Med. 2016 Oct;23(5):606-10. doi: 10.1007/s12529-016-9550-2.
- Inter-rater reliability of clinical mobility measures in ankylosing spondylitis.
Calvo-Gutiérrez J, Garrido-Castro JL, González-Navas C, Castro-Villegas MC, Ortega-Castro R, López-Medina C, Font-Ugalde P, Escudero-Contreras A, Collantes-Estévez E.
BMC Musculoskelet Disord. 2016 Sep 5;17(1):382. doi: 10.1186/s12891-016-1242-1.
- Evaluation of the impact of nursing clinics in the rheumatology services.
Muñoz-Fernández S, Aguilar MD, Rodríguez A, Almodóvar R, Cano-García L, Gracia LA, Román-Ivorra JA, Rodríguez JR, Navío T, Lázaro P; SCORE Working Group..
Rheumatol Int. 2016 Sep;36(9):1309-17. doi: 10.1007/s00296-016-3518-z.
- Atherothrombosis-associated microRNAs in Antiphospholipid syndrome and Systemic Lupus Erythematosus patients.
Pérez-Sánchez C, Aguirre MA, Ruiz-Limón P, Barbarroja N, Jiménez-Gómez Y, de la Rosa IA, Rodriguez-Ariza A, Collantes-Estévez E, Segui P, Velasco F, Cuadrado MJ, Teruel R, González-Conejero R, Martínez C, López-Pedrera Ch.
Sci Rep. 2016 Aug 9;6:31375. doi: 10.1038/srep31375.
- Assessment of Fatigue in Spondyloarthritis and Its Association with Disease Activity.
López-Medina C, Schiotis RE, Font-Ugalde P, Castro-Villegas MC, Calvo-Gutiérrez J, Ortega-Castro R, Jiménez-Gasco R, Escudero-Contreras A, Collantes-Estévez E; REGISPONSER Working Group..
J Rheumatol. 2016 Apr;43(4):751-7. doi: 10.3899/jrheum.150832.
- Altered S-nitrosothiol homeostasis provides a survival advantage to breast cancer cells in HER2 tumors and reduces their sensitivity to trastuzumab.
Cañas A, López-Sánchez LM, Peñarando J, Valverde A, Conde F, Hernández V, Fuentes E, López-Pedrera C, de la Haba-Rodríguez JR, Aranda E, Rodríguez-Ariza A.
Biochim Biophys Acta. 2016 Apr;1862(4):601-10. doi: 10.1016/j.bbadis.2016.02.005.
- Real-world cost-effectiveness of infliximab, etanercept and adalimumab in rheumatoid arthritis patients: results of the CREATE registry.
Cárdenas M, de la Fuente S, Font P, Castro-Villegas M, Romero-Gómez M, Ruiz-Vílchez D, Calvo-Gutiérez J, Escudero-Contreras A, Casado M, Del Prado J, Collantes-Estévez E.
Rheumatol Int. 2016 Feb;36(2):231-41.
- Etoricoxib in ankylosing spondylitis: is there a role for active patients refractory to traditional NSAIDs?
Gratacós J, Moreno Martínez-Losa M, Font P, Montilla C, Fernández-Espartero C, Linares LF, Brito E, Oliva JC, Collantes-Estevez E; Etoricoxib Study Group..
Clin Exp Rheumatol. 2016 Jan-Feb;34(1):94-9.
- Predictive validity of the ASAS classification criteria for axial and peripheral spondyloarthritis after follow-up in the ASAS cohort: a final analysis.
Sepriano A, Landewé R, van der Heijde D, Sieper J, Akkoc N, Brandt J, Braun J, Collantes-Estevez E, Dougados M, Fitzgerald O, Huang F, Gu J, Kirazli Y, Maksymowych WP, Marzo-Ortega H, Olivieri I, Ozgocmen S, Roussou E, Scarpato S, Sørensen IJ, Valle-Oñate R, Van den Bosch F, van der Horst-Bruinsma I, Weber U, Wei J, Rudwaleit M; ASAS..
Ann Rheum Dis. 2016 Jun;75(6):1034-42. doi: 10.1136/annrheumdis-2015-208730.
- Prevalence of comorbidities and evaluation of their screening in spondyloarthritis: results of the international cross-sectional ASAS-COMOSPA study.
Moltó A, Etcheto A, van der Heijde D, Landewé R, van den Bosch F, Bautista Molano W, Burgos-Vargas R, Cheung PP, Collantes-Estevez E, Deodhar A, El-Zorkany B, Erdes S, Gu J, Hajjaj-Hassouni N, Kiltz U, Kim TH, Kishimoto M, Luo SF, Machado PM, Maksymowych WP, Maldonado-Cocco J, Marzo-Ortega H, Montecucco CM, Ozgoçmen S, van Gaalen F, Dougados M.
Ann Rheum Dis. 2016 Jun;75(6):1016-23. doi: 10.1136/annrheumdis-2015-208174.
2015
- Immunotherapy in antiphospholipid syndrome.
Lopez-Pedrera Ch, Aguirre MA, Ruiz-Limon P, Pérez-Sánchez C, Jimenez-Gomez Y, Barbarroja N, Cuadrado MJ.
Int Immunopharmacol. 2015 Aug;27(2):200-8. doi: 10.1016/j.intimp.2015.06.006. Review.
- ASDAS high disease activity versus BASDAI elevation in patients with ankylosing spondylitis as selection criterion for anti-TNF therapy.
Vastesaeger N, Cruyssen BV, Mulero J, Gratacós Masmitjá J, Zarco P, Almodovar R, Font P, Juanola X, Collantes-Estevez E; REGISPONSER Working Group..
Reumatol Clin. 2014 Jul-Aug;10(4):204-9. doi: 10.1016/j.reuma.2013.12.006.
- Confirmation of CCR6 as a risk factor for anti-topoisomerase I antibodies in systemic sclerosis.
Ochoa E, Martin JE, Assasi S, Beretta L, Carreira P, Guillén A, Simeón CP, Koumakis E, Dieude P, Allanore Y, García-Hernández FJ, Espinosa G, Castellví I, Trapiella JL, Rodriguez L, González-Gay MÁ, Egurbide MV, Sáez L, Callejas-Rubio JL, Vargas-Hitos JA, Hunzelmann N, Riemekasten G, Witte T, Distler JH, Kreuter A, Lunardi C, Santaniello A, Tan FK, Shiels PG, Herrick A, Worthington J, Vonk MC, Koeleman BP, Radstake TR, Mayes MD, Martin J; Spanish Scleroderma Group..
Clin Exp Rheumatol. 2015 Jul-Aug;33(4 Suppl 91):S31-5.
- Gene profiling reveals specific molecular pathways in the pathogenesis of atherosclerosis and cardiovascular disease in antiphospholipid syndrome, systemic lupus erythematosus and antiphospholipid syndrome with lupus.
Perez-Sanchez C, Barbarroja N, Messineo S, Ruiz-Limon P, Rodriguez-Ariza A, Jimenez-Gomez Y, Khamashta MA, Collantes-Estevez E, Cuadrado MJ, Aguirre MA, Lopez-Pedrera C.
Ann Rheum Dis. 2015 Jul;74(7):1441-9. doi: 10.1136/annrheumdis-2013-204600.
- Atherosclerosis and cardiovascular disease in systemic lupus erythematosus: effects of in vivo statin treatment .
Ruiz-Limon P, Barbarroja N, Perez-Sanchez C, Aguirre MA, Bertolaccini ML, Khamashta MA, Rodriguez-Ariza A, Almadén Y, Segui P, Khraiwesh H, Gonzalez-Reyes JA, Villalba JM, Collantes-Estevez E, Cuadrado MJ, Lopez-Pedrera C.
Ann Rheum Dis. 2015 Jul;74(7):1450-8. doi: 10.1136/annrheumdis-2013-204351.
- Simultaneous inhibition of EGFR/VEGFR and cyclooxygenase-2 targets stemness-related pathways in colorectal cancer cells.
Valverde A, Peñarando J, Cañas A, López-Sánchez LM, Conde F, Hernández V, Peralbo E, López-Pedrera C, de la Haba-Rodríguez J, Aranda E, Rodríguez-Ariza A.
PLoS One. 2015 Jun 24;10(6):e0131363. doi: 10.1371/journal.pone.0131363.
- Proof-of-concept study demonstrating the pathogenicity of affinity-purified IgG antibodies directed to domain I of β2-glycoprotein I in a mouse model of anti-phospholipid antibody-induced thrombosis.
Pericleous C, Ruiz-Limón P, Romay-Penabad Z, Marín AC, Garza-Garcia A, Murfitt L, Driscoll PC, Latchman DS, Isenberg DA, Giles I, Ioannou Y, Rahman A, Pierangeli SS.
Rheumatology (Oxford). 2015 Apr;54(4):722-7. doi: 10.1093/rheumatology/keu360.
- Increased dihydroceramide/ceramide ratio mediated by defective expression of degs1 impairs adipocyte differentiation and function.
Barbarroja N, Rodriguez-Cuenca S, Nygren H, Camargo A, Pirraco A, Relat J, Cuadrado I, Pellegrinelli V, Medina-Gomez G, Lopez-Pedrera C, Tinahones FJ, Symons JD, Summers SA, Oresic M, Vidal-Puig A.
Diabetes. 2015 Apr;64(4):1180-92. doi: 10.2337/db14-0359.
- Reccomendations for the detection, study and referral of inflammatory low-back pain in primary care.
Juanola Roura X, Collantes Estévez E, León Vázquez F, Torres Villamor A, García Yébenes MJ, Queiro Silva R, Gratacós Masmitja J, García Criado E, Giménez S, Carmona L; Grupo de estudio para el Dolor Lumbar Inflamatorio..
Reumatol Clin. 2015 Mar-Apr;11(2):90-8. doi: 10.1016/j.reuma.2014.04.007.
- PXK locus in systemic lupus erythematosus: fine mapping and functional analysis reveals novel susceptibility gene ABHD6. Oparina NY, Delgado-Vega AM, Martinez-Bueno M, Magro-Checa C, Fernández C, Castro RO, Pons-Estel BA, D'Alfonso S, Sebastiani GD, Witte T, Lauwerys BR, Endreffy E, Kovács L, Escudero A, López-Pedrera C, Vasconcelos C, da Silva BM, Frostegård J, Truedsson L, Martin J, Raya E, Ortego-Centeno N, de Los Angeles Aguirre M, de Ramón Garrido E, Palma MJ, Alarcon-Riquelme ME, Kozyrev SV.
Ann Rheum Dis. 2015 Mar;74(3):e14. doi: 10.1136/annrheumdis-2013-204909.
- Circulating miRNAs as potential biomarkers of therapy effectiveness in rheumatoid arthritis patients treated with anti-TNFα.
Castro-Villegas C, Pérez-Sánchez C, Escudero A, Filipescu I, Verdu M, Ruiz-Limón P, Aguirre MA, Jiménez-Gomez Y, Font P, Rodriguez-Ariza A, Peinado JR, Collantes-Estévez E, González-Conejero R, Martinez C, Barbarroja N, López-Pedrera C.
Arthritis Res Ther. 2015 Mar 9;17:49. doi: 10.1186/s13075-015-0555-z.
- Erratum to: Nonradiographic axial spondyloarthritis. What brings the new concept?
Collantes-Estevez E, Espinoza LR.
Clin Rheumatol. 2015 Feb;34(2):199. doi: 10.1007/s10067-014-2852-3. No abstract available.
- Nonradiographic axial spondyloarthritis. What brings the new concept?
Collantes-Estevez E, Espinoza LR.
Clin Rheumatol. 2015 Feb;34(2):195-7. doi: 10.1007/s10067-014-2805-x. No abstract available. Erratum in: Clin Rheumatol. 2015 Feb;34(2):199. Espinosa, Luis R [corrected to Espinoza, Luis R].
- Dihydroceramide desaturase 1, the gatekeeper of ceramide induced lipotoxicity.
Rodriguez-Cuenca S, Barbarroja N, Vidal-Puig A.
Biochim Biophys Acta. 2015 Jan;1851(1):40-50. doi: 10.1016/j.bbalip.2014.09.021. Review.
- Is spinal mobility in patients with spondylitis determined by age, structural damage, and inflammation?
Calvo-Gutierrez J, Garrido-Castro JL, Gil-Cabezas J, Gonzalez-Navas C, Ugalde PF, Carmona L, Collantes-Estevez E.
Arthritis Care Res (Hoboken). 2015 Jan;67(1):74-9. doi: 10.1002/acr.22400.
- Human mesenchymal stromal cell lysates as a novel strategy to recover liver function.
Herencia C, Almadén Y, Martínez-Moreno JM, Espejo I, Herrera C, Pérez-Sánchez C, Guerrero F, Ciria R, Briceño FJ, Ferrín G, de la Mata M, Muñoz-Castañeda JR.
Regen Med. 2015;10(1):25-38. doi: 10.2217/rme.14.59.
2014
- Anticyclic citrullinated protein antibodies are implicated in the development of cardiovascular disease in rheumatoid arthritis.
Barbarroja N, Pérez-Sanchez C, Ruiz-Limon P, Castro-Villegas C, Aguirre MA, Carretero R, Segui P, Jimenez-Gomez Y, Sanna M, Rodriguez-Ariza A, Collantes-Estevez E, Escudero A, López-Pedrera C.
Arterioscler Thromb Vasc Biol. 2014 Dec;34(12):2706-16. doi: 10.1161/ATVBAHA.114.304475.
- Ankylosing spondylitis without axial progression: analysis of associated factors.
Montilla C, Díaz-Alvarez A, Calero-Paniagua I, Collantes-Estevez E, Font P, Almodovar R, Zarco P, Queiro-Silva R, Cañete JD, Juanola X, Mulero J, de Miguel E, Gratacós J; REGISPONSER Study Group..
J Rheumatol. 2014 Dec;41(12):2409-12. doi: 10.3899/jrheum.140018.
- Effect of dietary fat modification on subcutaneous white adipose tissue insulin sensitivity in patients with metabolic syndrome.
Jimenez-Gomez Y, Cruz-Teno C, Rangel-Zuñiga OA, Peinado JR, Perez-Martinez P, Delgado-Lista J, Garcia-Rios A, Camargo A, Vazquez-Martinez R, Ortega-Bellido M, Perez-Jimenez F, Roche HM, Malagon MM, Lopez-Miranda J.
Mol Nutr Food Res. 2014 Nov;58(11):2177-88. doi: 10.1002/mnfr.201300901.
- Development and validation of a new instrument to measure health-related quality of life in patients with psoriatic arthritis: the VITACORA-19.
Torre-Alonso JC, Gratacós J, Rey-Rey JS, Valdazo de Diego JP, Urriticoechea-Arana A, Daudén E, Moreno M, Zarco-Montejo P, Collantes-Estévez E, Fernández-López JA.
J Rheumatol. 2014 Oct;41(10):2008-17. doi: 10.3899/jrheum.131021.
- Validity of the ankylosing spondylitis disease activity score (ASDAS) in patients with early spondyloarthritis from the Esperanza programme.
Fernández-Espartero C, de Miguel E, Loza E, Tomero E, Gobbo M, Descalzo MA, Collantes-Estévez E, Mulero J, Muñoz-Fernández S, Zarco P, Carmona L; ESPERANZA Study Group..
Ann Rheum Dis. 2014 Jul;73(7):1350-5. doi: 10.1136/annrheumdis-2012-202976.
- A prospective open-label pilot study of fluvastatin on proinflammatory and prothrombotic biomarkers in antiphospholipid antibody positive patients.
Erkan D, Willis R, Murthy VL, Basra G, Vega J, Ruiz-Limón P, Carrera AL, Papalardo E, Martínez-Martínez LA, González EB, Pierangeli SS.
Ann Rheum Dis. 2014 Jun;73(6):1176-80. doi: 10.1136/annrheumdis-2013-203622.
- Candidate's single-nucleotide polymorphism predictors of treatment nonresponse to the first anti-TNF inhibitor in ankylosing spondylitis.
Schiotis R, Sánchez A, Escudero A, Bartolomé N, Szczypiorska M, Font P, Martínez A, Tejedor D, Artieda M, Mulero J, Buzoianu A, Collantes-Estévez E.
Rheumatol Int. 2014 Jun;34(6):793-801. doi: 10.1007/s00296-013-2913-y.
- CoCl2, a mimic of hypoxia, induces formation of polyploid giant cells with stem characteristics in colon cancer.
Lopez-Sánchez LM, Jimenez C, Valverde A, Hernandez V, Peñarando J, Martinez A, Lopez-Pedrera C, Muñoz-Castañeda JR, De la Haba-Rodríguez JR, Aranda E, Rodriguez-Ariza A.
PLoS One. 2014 Jun 16;9(6):e99143. doi: 10.1371/journal.pone.0099143.
- Validation of a new objective index to measure spinal mobility: the University of Cordoba Ankylosing Spondylitis Metrology Index (UCOASMI).
Garrido-Castro JL, Escudero A, Medina-Carnicer R, Galisteo AM, Gonzalez-Navas C, Carmona L, Collantes-Estevez E.
Rheumatol Int. 2014 Mar;34(3):401-6. doi: 10.1007/s00296-013-2917-7.
- Performance of the Assessment of Spondyloarthritis International Society criteria for the classification of spondyloarthritis in early spondyloarthritis clinics participating in the ESPERANZA programme.
Tomero E, Mulero J, de Miguel E, Fernández-Espartero C, Gobbo M, Descalzo MA, Collantes-Estévez E, Zarco P, Muñoz-Fernández S, Carmona L; ESPERANZA Study Group..
Rheumatology (Oxford). 2014 Feb;53(2):353-60. doi: 10.1093/rheumatology/ket359.
- Proteomic approaches to evaluate protein S-nitrosylation in disease.
López-Sánchez LM, López-Pedrera C, Rodríguez-Ariza A.
Mass Spectrom Rev. 2014 Jan-Feb;33(1):7-20. doi: 10.1002/mas.21373. Review.
- Dietary fat differentially influences the lipids storage on the adipose tissue in metabolic syndrome patients.
Camargo A, Meneses ME, Perez-Martinez P, Delgado-Lista J, Jimenez-Gomez Y, Cruz-Teno C, Tinahones FJ, Paniagua JA, Perez-Jimenez F, Roche HM, Malagon MM, Lopez-Miranda J.
Eur J Nutr. 2014;53(2):617-26. doi: 10.1007/s00394-013-0570-2.
- Treating spondyloarthritis, including ankylosing spondylitis and psoriatic arthritis, to target: recommendations of an international task force.
Smolen JS, Braun J, Dougados M, Emery P, Fitzgerald O, Helliwell P, Kavanaugh A, Kvien TK, Landewé R, Luger T, Mease P, Olivieri I, Reveille J, Ritchlin C, Rudwaleit M, Schoels M, Sieper J, Wit Md, Baraliakos X, Betteridge N, Burgos-Vargas R, Collantes-Estevez E, Deodhar A, Elewaut D, Gossec L, Jongkees M, Maccarone M, Redlich K, van den Bosch F, Wei JC, Winthrop K, van der Heijde D.
Ann Rheum Dis. 2014 Jan;73(1):6-16. doi: 10.1136/annrheumdis-2013-203419.
2013
- Value of isolated IgA anti-β2 -glycoprotein I positivity in the diagnosis of the antiphospholipid syndrome.
Murthy V, Willis R, Romay-Penabad Z, Ruiz-Limón P, Martínez-Martínez LA, Jatwani S, Jajoria P, Seif A, Alarcón GS, Papalardo E, Liu J, Vilá LM, McGwin G Jr, McNearney TA, Maganti R, Sunkureddi P, Parekh T, Tarantino M, Akhter E, Fang H, Gonzalez EB, Binder WR, Norman GL, Shums Z, Teodorescu M, Reveille JD, Petri M, Pierangeli SS.
Arthritis Rheum. 2013 Dec;65(12):3186-93. doi: 10.1002/art.38131
- Adipobiology for novel therapeutic approaches in metabolic syndrome.
Malagón MM, Díaz-Ruiz A, Guzmán-Ruiz R, Jiménez-Gómez Y, Moreno NR, García-Navarro S, Vázquez-Martínez R, Peinado JR.
Curr Vasc Pharmacol. 2013 Nov;11(6):954-67. Review.
- Adaptive changes of the Insig1/SREBP1/SCD1 set point help adipose tissue to cope with increased storage demands of obesity.
Carobbio S, Hagen RM, Lelliott CJ, Slawik M, Medina-Gomez G, Tan CY, Sicard A, Atherton HJ, Barbarroja N, Bjursell M, Bohlooly-Y M, Virtue S, Tuthill A, Lefai E, Laville M, Wu T, Considine RV, Vidal H, Langin D, Oresic M, Tinahones FJ, Fernandez-Real JM, Griffin JL, Sethi JK, López M, Vidal-Puig A.
Diabetes. 2013 Nov;62(11):3697-708. doi: 10.2337/db12-1748.
- Resveratrol improves adipose insulin signaling and reduces the inflammatory response in adipose tissue of rhesus monkeys on high-fat, high-sugar diet.
Jimenez-Gomez Y, Mattison JA, Pearson KJ, Martin-Montalvo A, Palacios HH, Sossong AM, Ward TM, Younts CM, Lewis K, Allard JS, Longo DL, Belman JP, Malagon MM, Navas P, Sanghvi M, Moaddel R, Tilmont EM, Herbert RL, Morrell CH, Egan JM, Baur JA, Ferrucci L, Bogan JS, Bernier M, de Cabo R.
Cell Metab. 2013 Oct 1;18(4):533-45. doi: 10.1016/j.cmet.2013.09.004.
- New paradigms in the diagnosis and classification of the spondylarthritis.
Collantes-Estevez E.
Reumatol Clin. 2013 Jul-Aug;9(4):199-200. doi: 10.1016/j.reuma.2013.04.002.
- An analysis of 372 patients with anterior uveitis in a large Ibero-American cohort of spondyloarthritis: the RESPONDIA Group.
Sampaio-Barros PD, Pereira IA, Hernández-Cuevas C, Berman A, Burgos-Vargas R, Gutierrez MA, Barcelos A, Chávez-Corrales JE, Moreno M, Palleiro DR, Saénz-Castro R, Stekman I, Azevedo VF, Braga-da-Silva JA, Citera G, Flores-Alvarado D, Gonçalves CR, Graf C, Nitsche A, Saavedra J, Ximenes AC, Vázquez-Mellado J, Collantes-Estevez E; Respondia Group..
Clin Exp Rheumatol. 2013 Jul-Aug;31(4):484-9.
- Different clinical expression of patients with ankylosing spondylitis according to gender in relation to time since onset of disease. Data from REGISPONSER.
Ortega Castro R, Font Ugalde P, Castro Villegas MC, Calvo Gutiérrez J, Muñoz Gomariz E, Zarco Montejo P, Almodóvar R, Mulero Mendoza J, Torre-Alonso JC, Gratacós Masmitjá J, Juanola Roura X, Ariza Ariza R, Fernández Dapica P, Linares Ferrando LF, Brito Brito ME, Cuende Quintana E, Vázquez Galeano C, Moreno Ramos MJ, Giménez Úbeda E, Rodríguez Lozano JC, Fernández Prada M, Queiro Silva R, Moreno Ruzafa E, Júdez Navarro E, Más AJ, Medrano Le Quement C, Ornilla E, Montilla Morales C, Pujol Busquets M, Clavaguera Poch T, Fernández-Espartero MC, Carmona Ortell L, Collantes Estévez E.
Reumatol Clin. 2013 Jul-Aug;9(4):221-5. doi: 10.1016/j.reuma.2012.09.008.
- Hip disease in ankylosing spondylitis.
Vander Cruyssen B, Vastesaeger N, Collantes-Estévez E.
Curr Opin Rheumatol. 2013 Jul;25(4):448-54. doi: 10.1097/BOR.0b013e3283620e04. Review.
- Model of excellence in Rheumatology Day Hospitals in Spain: the HD-Reumatolex project.
Román Ivorra JA, Sanmarti R, Collantes-Estévez E, Carreño Pérez L, Betegón L.
Reumatol Clin. 2013 May-Jun;9(3):142-7. doi: 10.1016/j.reuma.2012.07.001. English, Spanish.
- Caspase induction and BCL2 inhibition in human adipose tissue: a potential relationship with insulin signaling alteration.
Tinahones FJ, Coín Aragüez L, Murri M, Oliva Olivera W, Mayas Torres MD, Barbarroja N, Gomez Huelgas R, Malagón MM, El Bekay R.
Diabetes Care. 2013 Mar;36(3):513-21. doi: 10.2337/dc12-0194.
2012
- Comparison of the clinical expression of patients with ankylosing spondylitis from Europe and Latin America .
Benegas M, Muñoz-Gomariz E, Font P, Burgos-Vargas R, Chaves J, Palleiro D, Maldonado Cocco J, Gutiérrez M, Sáenz R, Steckmen I, Rillo O, Mulero J, Sampaio-Barros P, Barcelos A, Vander Cruyssen B, Vazquez-Mellado J, Collantes Estevez E; RESPONDIA group.; ASPECT study group.; REGISPONSER study group..
J Rheumatol. 2012 Dec;39(12):2315-20. doi: 10.3899/jrheum.110687.
- Maintenance of S-nitrosothiol homeostasis plays an important role in growth suppression of estrogen receptor-positive breast tumors.
Cañas A, López-Sánchez LM, Valverde-Estepa A, Hernández V, Fuentes E, Muñoz-Castañeda JR, López-Pedrera C, De La Haba-Rodríguez JR, Aranda E, Rodríguez-Ariza A.
Breast Cancer Res. 2012 Dec 5;14(6):R153. doi: 10.1186/bcr3366.
- Progression from high insulin resistance to type 2 diabetes does not entail additional visceral adipose tissue inflammation.
Barbarroja N, Lopez-Pedrera C, Garrido-Sanchez L, Mayas MD, Oliva-Olivera W, Bernal-Lopez MR, El Bekay R, Tinahones FJ.
PLoS One. 2012;7(10):e48155. doi: 10.1371/journal.pone.0048155.
- Both baseline clinical factors and genetic polymorphisms influence the development of severe functional status in ankylosing spondylitis.
Schiotis R, Bartolomé N, Sánchez A, Szczypiorska M, Sanz J, Cuende E, Collantes Estevez E, Martínez A, Tejedor D, Artieda M, Buzoianu A, Mulero J.
PLoS One. 2012;7(9):e43428. doi: 10.1371/journal.pone.0043428.
- Assessment of spinal mobility in ankylosing spondylitis using a video-based motion capture system.
Garrido-Castro JL, Medina-Carnicer R, Schiottis R, Galisteo AM, Collantes-Estevez E, Gonzalez-Navas C.
Man Ther. 2012 Oct;17(5):422-6. doi: 10.1016/j.math.2012.03.011.
- Ablation of PGC1 beta prevents mTOR dependent endoplasmic reticulum stress response.
Camacho A, Rodriguez-Cuenca S, Blount M, Prieur X, Barbarroja N, Fuller M, Hardingham GE, Vidal-Puig A.
Exp Neurol. 2012 Oct;237(2):396-406. doi: 10.1016/j.expneurol.2012.06.031. Erratum in: Exp Neurol. 2013 Jan;239:101.
- Catastrophic antiphospholipid syndrome (CAPS).
Sciascia S, Lopez-Pedrera C, Roccatello D, Cuadrado MJ.
Best Pract Res Clin Rheumatol. 2012 Aug;26(4):535-41. doi: 10.1016/j.berh.2012.07.005. Review.
- Mitochondrial dysfunction in antiphospholipid syndrome: implications in the pathogenesis of the disease and effects of coenzyme Q(10) treatment.
Perez-Sanchez C, Ruiz-Limon P, Aguirre MA, Bertolaccini ML, Khamashta MA, Rodriguez-Ariza A, Segui P, Collantes-Estevez E, Barbarroja N, Khraiwesh H, Gonzalez-Reyes JA, Villalba JM, Velasco F, Cuadrado MJ, Lopez-Pedrera C.
Blood. 2012 Jun 14;119(24):5859-70. doi: 10.1182/blood-2011-12-400986.
- Dietary fat modifies the postprandial inflammatory state in subjects with metabolic syndrome: the LIPGENE study.
Cruz-Teno C, Pérez-Martínez P, Delgado-Lista J, Yubero-Serrano EM, García-Ríos A, Marín C, Gómez P, Jiménez-Gómez Y, Camargo A, Rodríguez-Cantalejo F, Malagón MM, Pérez-Jiménez F, Roche HM, López-Miranda J.
Mol Nutr Food Res. 2012 Jun;56(6):854-65. doi: 10.1002/mnfr.201200096.
- Proteomics insights into deregulated protein S-nitrosylation and disease.
López-Sánchez LM, López-Pedrera C, Rodríguez-Ariza A.
Expert Rev Proteomics. 2012;9(1):59-69. doi: 10.1586/epr.11.74. Review.
- To cardiovascular disease and beyond: new therapeutic perspectives of statins in autoimmune diseases and cancer.
Lopez-Pedrera C, Ruiz-Limon P, Valverde-Estepa A, Barbarroja N, Rodriguez-Ariza A.
Curr Drug Targets. 2012 Jun;13(6):829-41. Review.
- Clinical features of late-onset ankylosing spondylitis: comparison with early-onset disease.
Montilla C, Del Pino-Montes J, Collantes-Estevez E, Font P, Zarco P, Mulero J, Gratacós J, Rodríguez C, Juanola X, Fernández-Sueiro JL, Almodovar R; REGISPONSER Study Group..
J Rheumatol. 2012 May;39(5):1008-12. doi: 10.3899/jrheum.111082.
- Peroxisome proliferator-activated receptor γ-dependent regulation of lipolytic nodes and metabolic flexibility.
Rodriguez-Cuenca S, Carobbio S, Velagapudi VR, Barbarroja N, Moreno-Navarrete JM, Tinahones FJ, Fernandez-Real JM, Orešic M, Vidal-Puig A.
Mol Cell Biol. 2012 Apr;32(8):1555-65. doi: 10.1128/MCB.06154-11.
- How to optimize the antiTNF alpha therapy in spondylitis?
Castro Villegas Mdel C, Escudero Contreras A, Miranda García MD, Collantes Estévez E.
Reumatol Clin. 2012 Mar;8 Suppl 1:S26-31. doi: 10.1016/j.reuma.2012.01.002. Review. Spanish.
- Our scientific production in the field of spondyloarthritis.
Collantes Estévez E; Grupo Español de Espondiloartritis (GRESSER)..
Reumatol Clin. 2012 Mar;8 Suppl 1:S42-5. doi: 10.1016/j.reuma.2012.02.001
- Potential use of statins in the treatment of antiphospholipid syndrome.
Lopez-Pedrera C, Ruiz-Limon P, Aguirre MA, Rodriguez-Ariza A, Cuadrado MJ.
Curr Rheumatol Rep. 2012 Feb;14(1):87-94. doi: 10.1007/s11926-011-0222-6. Review.
- Nitric oxide and cancer: the emerging role of S-nitrosylation.
Aranda E, López-Pedrera C, De La Haba-Rodriguez JR, Rodriguez-Ariza A.
Curr Mol Med. 2012 Jan;12(1):50-67. Review.
- Cardiovascular risk in systemic autoimmune diseases: epigenetic mechanisms of immune regulatory functions.
López-Pedrera C, Pérez-Sánchez C, Ramos-Casals M, Santos-Gonzalez M, Rodriguez-Ariza A, Cuadrado MJ.
Clin Dev Immunol. 2012;2012:974648. doi: 10.1155/2012/974648. Review.
2011
- Postprandial inflammatory response in adipose tissue of patients with metabolic syndrome after the intake of different dietary models.
Meneses ME, Camargo A, Perez-Martinez P, Delgado-Lista J, Cruz-Teno C, Jimenez-Gomez Y, Paniagua JA, Gutierrez-Mariscal FM, Tinahones FJ, Vidal-Puig A, Roche HM, Perez-Jimenez F, Malagon MM, Lopez-Miranda J.
Mol Nutr Food Res. 2011 Dec;55(12):1759-70. doi: 10.1002/mnfr.201100200.
- Efficacy and safety of abatacept in patients with rheumatoid arthritis and no prior treatment with biologics.
Escudero Contreras A, Castro-Villegas MC, Hernández-Hernández MV, Díaz-González F.
Reumatol Clin. 2011 Nov-Dec;7(6):392-6. doi: 10.1016/j.reuma.2011.06.007
- VEGF targeted therapy in acute myeloid leukemia.
Rodriguez-Ariza A, Lopez-Pedrera C, Aranda E, Barbarroja N.
Crit Rev Oncol Hematol. 2011 Nov;80(2):241-56. doi: 10.1016/j.critrevonc.2010.09.009. Review.
- Study of the potential association of adipose tissue GLP-1 receptor with obesity and insulin resistance.
Vendrell J, El Bekay R, Peral B, García-Fuentes E, Megia A, Macias-Gonzalez M, Fernández Real J, Jimenez-Gomez Y, Escoté X, Pachón G, Simó R, Selva DM, Malagón MM, Tinahones FJ.
Endocrinology. 2011 Nov;152(11):4072-9. doi: 10.1210/en.2011-1070.
- Identification of miRNAs as potential modulators of tissue factor expression in patients with systemic lupus erythematosus and antiphospholipid syndrome.
Teruel R, Pérez-Sánchez C, Corral J, Herranz MT, Pérez-Andreu V, Saiz E, García-Barberá N, Martínez-Martínez I, Roldán V, Vicente V, López-Pedrera C, Martínez C.
J Thromb Haemost. 2011 Oct;9(10):1985-92. doi: 10.1111/j.1538-7836.2011.04451.x.
- Consensus statement of the Spanish Society of Rheumatology on risk management of biologic therapy in rheumatic patients.
Gómez Reino J, Loza E, Andreu JL, Balsa A, Batlle E, Cañete JD, Collantes Estévez E, Fernández Carballido C, Fernández Sueiro JL, García de Vicuña R, González-Álvaro I, González Fernández C, Juanola X, Linares LF, Marenco JL, Martín Mola E, Moreno Ramos M, Mulero Mendoza J, Muñoz Fernández S, Queiro R, Richi Alberti P, Sanz J, Tornero Molina J, Zarco Montejo P, Carmona L; Sociedad Española de Reumatología..
Reumatol Clin. 2011 Sep-Oct;7(5):284-98. doi: 10.1016/j.reuma.2011.05.002.
- Rab18 dynamics in adipocytes in relation to lipogenesis, lipolysis and obesity.
Pulido MR, Diaz-Ruiz A, Jiménez-Gómez Y, Garcia-Navarro S, Gracia-Navarro F, Tinahones F, López-Miranda J, Frühbeck G, Vázquez-Martínez R, Malagón MM.
PLoS One. 2011;6(7):e22931. doi: 10.1371/journal.pone.0022931.
- Differential features between primary ankylosing spondylitis and spondylitis associated with psoriasis and inflammatory bowel disease.
Pérez Alamino R, Maldonado Cocco JA, Citera G, Arturi P, Vazquez-Mellado J, Sampaio-Barros PD, Flores D, Burgos-Vargas R, Santos H, Chavez-Corrales JE, Palleiro D, Gutierrez MA, Vieira-Sousa E, Pimentel-Santos FM, Paira S, Berman A, Moreno-Alvarez M, Collantes-Estevez E; RESPONDIA Group..
J Rheumatol. 2011 Aug;38(8):1656-60. doi: 10.3899/jrheum.101049.
- 2010 update of the ASAS/EULAR recommendations for the management of ankylosing spondylitis.
Braun J, van den Berg R, Baraliakos X, Boehm H, Burgos-Vargas R, Collantes-Estevez E, Dagfinrud H, Dijkmans B, Dougados M, Emery P, Geher P, Hammoudeh M, Inman RD, Jongkees M, Khan MA, Kiltz U, Kvien T, Leirisalo-Repo M, Maksymowych WP, Olivieri I, Pavelka K, Sieper J, Stanislawska-Biernat E, Wendling D, Ozgocmen S, van Drogen C, van Royen B, van der Heijde D.
Ann Rheum Dis. 2011 Jun;70(6):896-904. doi: 10.1136/ard.2011.151027.
- Interleukin 1B variant -1473G/C (rs1143623) influences triglyceride and interleukin 6 metabolism.
Delgado-Lista J, Garcia-Rios A, Perez-Martinez P, Solivera J, Yubero-Serrano EM, Fuentes F, Parnell LD, Shen J, Gomez P, Jimenez-Gomez Y, Gomez-Luna MJ, Marin C, Belisle SE, Rodriguez-Cantalejo F, Meydani SN, Ordovas JM, Perez-Jimenez F, Lopez-Miranda J.
J Clin Endocrinol Metab. 2011 May;96(5):E816-20. doi: 10.1210/jc.2010-2455.
- Relative value of the lumbar spine and hip bone mineral density and bone turnover markers in men with ankylosing spondylitis.
Muntean L, Rojas-Vargas M, Font P, Simon SP, Rednic S, Schiotis R, Stefan S, Tamas MM, Bolosiu HD, Collantes-Estévez E.
Clin Rheumatol. 2011 May;30(5):691-5. doi: 10.1007/s10067-010-1648-3.
- Gene variations of nitric oxide synthase regulate the effects of a saturated fat rich meal on endothelial function.
Delgado-Lista J, Garcia-Rios A, Perez-Martinez P, Fuentes F, Jiménez-Gomez Y, Gomez-Luna MJ, Parnell LD, Marin C, Lai CQ, Perez-Jimenez F, Ordovas JM, Lopez-Miranda J.
Clin Nutr. 2011 Apr;30(2):234-8. doi: 10.1016/j.clnu.2010.08.006.
- Global effects of fluvastatin on the prothrombotic status of patients with antiphospholipid syndrome.
López-Pedrera C, Ruiz-Limón P, Aguirre MÁ, Barbarroja N, Pérez-Sánchez C, Buendía P, Rodriguez-García IC, Rodriguez-Ariza A, Collantes-Estevez E, Velasco F, Khasmahta M, Cuadrado MJ.
Ann Rheum Dis. 2011 Apr;70(4):675-82. doi: 10.1136/ard.2010.135525.
- Consensus Statement of the Spanish Society of Rheumatology on the management of biologic therapies in spondyloarthritis except for psoriatic arthritis.
Juanola Roura X, Zarco Montejo P, Sanz Sanz J, Muñoz Fernández S, Mulero Mendoza J, Linares Ferrando LF, Gratacós Masmitja J, García de Vicuña R, Fernandez Carballido C, Collantes Estevez E, Batlle Gualda E, Ariza Ariza R, Loza Santamaría E.
Reumatol Clin. 2011 Mar-Apr;7(2):113-23. doi: 10.1016/j.reuma.2010.12.002.
- Differential lipid partitioning between adipocytes and tissue macrophages modulates macrophage lipotoxicity and M2/M1 polarization in obese mice.
Prieur X, Mok CY, Velagapudi VR, Núñez V, Fuentes L, Montaner D, Ishikawa K, Camacho A, Barbarroja N, O'Rahilly S, Sethi JK, Dopazo J, Orešič M, Ricote M, Vidal-Puig A.
Diabetes. 2011 Mar;60(3):797-809. doi: 10.2337/db10-0705.
- Usefulness of a centralized system of data collection for the development of an international multicentre registry of spondyloarthritis.
Schiotis R, Font P, Escudero A, Zarco P, Almodovar R, Gratacós J, Mulero J, Juanola X, Montilla C, Moreno E, Ariza Ariza R, Collantes-Estevez E; REGISPONSER working group..
Rheumatology (Oxford). 2011 Jan;50(1):132-6. doi: 10.1093/rheumatology/keq253.
2010
- Accelerated atherosclerosis in systemic lupus erythematosus: role of proinflammatory cytokines and therapeutic approaches.
López-Pedrera C, Aguirre MÁ, Barbarroja N, Cuadrado MJ.
J Biomed Biotechnol. 2010;2010. pii: 607084. doi: 10.1155/2010/607084. Review.
- Current controversies in spondyloarthritis: SPARTAN.
Weisman M, Learch TJ, Baraliakos X, Chandran V, Gladman DD, Raychaudhuri SP, Xu H, Collantes-Estévez E, Vázquez-Mellado J, Mease PJ, Sieper J, Deodhar AA, Colbert RA, Clegg DO; SPARTAN Group..
J Rheumatol. 2010 Dec;37(12):2617-23. doi: 10.3899/jrheum.100890.
- AEE788 is a vascular endothelial growth factor receptor tyrosine kinase inhibitor with antiproliferative and proapoptotic effects in acute myeloid leukemia.
Barbarroja N, Torres LA, Rodriguez-Ariza A, Valverde-Estepa A, Lopez-Sanchez LM, Ruiz-Limon P, Perez-Sanchez C, Carretero RM, Velasco F, López-Pedrera C.
Exp Hematol. 2010 Aug;38(8):641-52. doi: 10.1016/j.exphem.2010.03.017.
- The obese healthy paradox: is inflammation the answer?
Barbarroja N, López-Pedrera R, Mayas MD, García-Fuentes E, Garrido-Sánchez L, Macías-González M, El Bekay R, Vidal-Puig A, Tinahones FJ.
Biochem J. 2010 Aug 15;430(1):141-9. doi: 10.1042/BJ20100285.
- The stromal-vascular fraction of adipose tissue contributes to major differences between subcutaneous and visceral fat depots.
Peinado JR, Jimenez-Gomez Y, Pulido MR, Ortega-Bellido M, Diaz-Lopez C, Padillo FJ, Lopez-Miranda J, Vazquez-Martínez R, Malagón MM.
Proteomics. 2010 Sep;10(18):3356-66. doi: 10.1002/pmic.201000350.
- A low-fat, high-complex carbohydrate diet supplemented with long-chain (n-3) fatty acids alters the postprandial lipoprotein profile in patients with metabolic syndrome.
Jiménez-Gómez Y, Marín C, Peérez-Martínez P, Hartwich J, Malczewska-Malec M, Golabek I, Kiec-Wilk B, Cruz-Teno C, Rodríguez F, Gómez P, Gómez-Luna MJ, Defoort C, Gibney MJ, Pérez-Jiménez F, Roche HM, López-Miranda J.
J Nutr. 2010 Sep;140(9):1595-601. doi: 10.3945/jn.109.120816.
- ES936 stimulates DNA synthesis in HeLa cells independently on NAD(P)H:quinone oxidoreductase 1 inhibition, through a mechanism involving p38 MAPK.
González-Aragón D, Alcaín FJ, Ariza J, Jódar L, Barbarroja N, López-Pedrera C, Villalba JM.
Chem Biol Interact. 2010 Jul 30;186(2):174-83. doi: 10.1016/j.cbi.2010.04.022.
- Drug-induced lupus.
Aguirre Zamorano MA, López Pedrera R, Cuadrado Lozano MJ.
Med Clin (Barc). 2010 Jun 19;135(3):124-9. doi: 10.1016/j.medcli.2009.04.035. Review. Spanish.
- Proteomics in antiphospholipid syndrome: a review.
Cuadrado MJ, Aguirre MA, Barbarroja N, Khamashta MA, Lopez-Pedrera Ch.
Lupus. 2010 Apr;19(4):385-8. doi: 10.1177/0961203309360986. Review.
- Differential expression of protease-activated receptors in monocytes from patients with primary antiphospholipid syndrome.
López-Pedrera C, Aguirre MA, Buendía P, Barbarroja N, Ruiz-Limón P, Collantes-Estevez E, Velasco F, Khamashta M, Cuadrado MJ.
Arthritis Rheum. 2010 Mar;62(3):869-77. doi: 10.1002/art.27299.
- Pharmacological impairment of s-nitrosoglutathione or thioredoxin reductases augments protein S-Nitrosation in human hepatocarcinoma cells.
López-Sánchez LM, Corrales FJ, López-Pedrera C, Aranda E, Rodríguez-Ariza A.
Anticancer Res. 2010 Feb;30(2):415-21.
2009
- Assessing the efficacy of non-arthroscopic joint lavage in patients with osteoarthritis of the knee.
Frías G, Font P, Muñoz-Gomariz E, Caracuel MA, Escudero A, Castro MC, Collantes-Estévez E.
Reumatol Clin. 2009 Sep-Oct;5(5):189-93. doi: 10.1016/j.reuma.2008.10.003.
- 2D versus 3D in the kinematic analysis of the horse at the trot.
Miró F, Santos R, Garrido-Castro JL, Galisteo AM, Medina-Carnicer R.
Vet Res Commun. 2009 Aug;33(6):507-13. doi: 10.1007/s11259-008-9196-x.
- Additive effect of PTK787/ZK 222584, a potent inhibitor of VEGFR phosphorylation, with Idarubicin in the treatment of acute myeloid leukemia.
Barbarroja N, Torres LA, Luque MJ, Carretero RM, Valverde-Estepa A, Lopez-Sanchez LM, Rodriguez-Ariza A, Velasco F, Torres A, López-Pedrera C.
Exp Hematol. 2009 Jun;37(6):679-91. doi: 10.1016/j.exphem.2009.03.001.
- Olive oil and walnut breakfasts reduce the postprandial inflammatory response in mononuclear cells compared with a butter breakfast in healthy men.
Jiménez-Gómez Y, López-Miranda J, Blanco-Colio LM, Marín C, Pérez-Martínez P, Ruano J, Paniagua JA, Rodríguez F, Egido J, Pérez-Jiménez F.
Atherosclerosis. 2009 Jun;204(2):e70-6. doi: 10.1016/j.atherosclerosis.2008.09.011.
- The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part I): classification of paper patients by expert opinion including uncertainty appraisal.
Rudwaleit M, Landewé R, van der Heijde D, Listing J, Brandt J, Braun J, Burgos-Vargas R, Collantes-Estevez E, Davis J, Dijkmans B, Dougados M, Emery P, van der Horst-Bruinsma IE, Inman R, Khan MA, Leirisalo-Repo M, van der Linden S, Maksymowych WP, Mielants H, Olivieri I, Sturrock R, de Vlam K, Sieper J.
Ann Rheum Dis. 2009 Jun;68(6):770-6. doi: 10.1136/ard.2009.108217. Erratum in: Ann Rheum Dis. 2011 Aug;70(8):1519.
- The development of Assessment of SpondyloArthritis international Society classification criteria for axial spondyloarthritis (part II): validation and final selection.
Rudwaleit M, van der Heijde D, Landewé R, Listing J, Akkoc N, Brandt J, Braun J, Chou CT, Collantes-Estevez E, Dougados M, Huang F, Gu J, Khan MA, Kirazli Y, Maksymowych WP, Mielants H, Sørensen IJ, Ozgocmen S, Roussou E, Valle-Oñate R, Weber U, Wei J, Sieper J.
Ann Rheum Dis. 2009 Jun;68(6):777-83. doi: 10.1136/ard.2009.108233.
- VEGF/KDR loop is a target of AG1296 in acute myeloid leukaemia showing FLT3-internal tandem duplications.
Torres LA, Barbarroja N, Dorado G, Velasco F, López-Pedrera C.
Br J Haematol. 2009 Jun;145(6):836-8. doi: 10.1111/j.1365-2141.2009.07673.x. No abstract available.
- New criteria for inflammatory back pain in patients with chronic back pain: a real patient exercise by experts from the Assessment of SpondyloArthritis international Society (ASAS).
Sieper J, van der Heijde D, Landewé R, Brandt J, Burgos-Vagas R, Collantes-Estevez E, Dijkmans B, Dougados M, Khan MA, Leirisalo-Repo M, van der Linden S, Maksymowych WP, Mielants H, Olivieri I, Rudwaleit M.
Ann Rheum Dis. 2009 Jun;68(6):784-8. doi: 10.1136/ard.2008.101501.
- First signs and symptoms of spondyloarthritis--data from an inception cohort with a disease course of two years or less (REGISPONSER-Early).
Rojas-Vargas M, Muñoz-Gomariz E, Escudero A, Font P, Zarco P, Almodovar R, Gratacós J, Mulero J, Juanola X, Montilla C, Moreno E, Collantes-Estevez E; Registro Español de Espondiloartritis de la Sociedad Española de Reumatología Working Group..
Rheumatology (Oxford). 2009 Apr;48(4):404-9. doi: 10.1093/rheumatology/ken506.
- First acute gout attacks commonly precede features of the metabolic syndrome.
Hernández-Cuevas CB, Roque LH, Huerta-Sil G, Rojas-Serrano J, Escudero A, Perez LL, Collantes-Estevez E, Vázquez Mellado J.
J Clin Rheumatol. 2009 Mar;15(2):65-7. doi: 10.1097/RHU.0b013e31819c0dba.
- Use of povidone-iodine during the first trimester of pregnancy: a correct practice?
Velasco I, Naranjo S, López-Pedrera C, Garriga MJ, García-Fuentes E, Soriguer F.
BJOG. 2009 Feb;116(3):452-5. doi: 10.1111/j.1471-0528.2008.02059.x.
- Novel biomarkers of atherosclerosis and cardiovascular risk in autoimmune diseases: Genomics and proteomics approaches.
López-Pedrera C, Barbarroja N, Villalba JM.
Proteomics Clin Appl. 2009 Feb;3(2):213-25. doi: 10.1002/prca.200800147.
2008
- Genomics and proteomics: a new approach for assessing thrombotic risk in autoimmune diseases.
López-Pedrera C, Barbarroja N, Aguirre MA, Torres LA, Velasco F, Cuadrado MJ.
Lupus. 2008 Oct;17(10):904-15. doi: 10.1177/0961203308095285. Review.
- Proteomic analysis in monocytes of antiphospholipid syndrome patients: deregulation of proteins related to the development of thrombosis.
López-Pedrera C, Cuadrado MJ, Herández V, Buendïa P, Aguirre MA, Barbarroja N, Torres LA, Villalba JM, Velasco F, Khamashta M.
Arthritis Rheum. 2008 Sep;58(9):2835-44. doi: 10.1002/art.23756.
- Adiponectin gene variants are associated with insulin sensitivity in response to dietary fat consumption in Caucasian men.
Pérez-Martínez P, López-Miranda J, Cruz-Teno C, Delgado-Lista J, Jiménez-Gómez Y, Fernández JM, Gómez MJ, Marín C, Pérez-Jiménez F, Ordovás JM.
J Nutr. 2008 Sep;138(9):1609-14.
- MEK inhibition induces caspases activation, differentiation blockade and PML/RARalpha degradation in acute promyelocytic leukaemia.
Barbarroja N, Siendones E, Torres LA, Luque MJ, Martinez JM, Dorado G, Velasco F, Torres A, López-Pedrera C.
Br J Haematol. 2008 Jul;142(1):27-35. doi: 10.1111/j.1365-2141.2008.07154.x.
- Development of a core set of domains for data collection in cohorts of patients with ankylosing spondylitis receiving anti-tumor necrosis factor-alpha therapy.
Zochling J, Sieper J, van der Heijde D, Braun J; Assessment in Ankylosing Spondylitis International Working Group..
J Rheumatol. 2008 Jun;35(6):1079-82.
- The burden of ankylosing spondylitis in Spain.
Kobelt G, Sobocki P, Mulero J, Gratacos J, Pocovi A, Collantes-Estevez E.
Value Health. 2008 May-Jun;11(3):408-15. doi: 10.1111/j.1524-4733.2007.00252.x.
- Intracellular mechanisms involved in the angiogenic process in hematological malignancies.
Barbarroja N, Velasco F, López-Pedrera C.
Med Clin (Barc). 2008 Apr 26;130(15):585-90. Review.
- The -250G/A polymorphism in the hepatic lipase gene promoter influences the postprandial lipemic response in healthy men.
Jiménez-Gómez Y, Pérez-Jiménez F, Marín C, Gómez P, Moreno R, Delgado J, Pérez-Martínez P, Gómez MJ, López-Miranda J.
Nutr Metab Cardiovasc Dis. 2008 Mar;18(3):173-81.
- The cost-effectiveness of infliximab in the treatment of ankylosing spondylitis in Spain. Comparison of clinical trial and clinical practice data.
Kobelt G, Sobocki P, Mulero J, Gratacos J, Collantes-Estevez E, Braun J.
Scand J Rheumatol. 2008 Jan-Feb;37(1):62-71. doi: 10.1080/03009740701607224.
- Chondrocalcinosis and hypomagnesemia: clinical and radiological progression.
González Domínguez J, Escudero Contreras A, Pérez Guijo V, Martínez Sánchez FG, Caracuel Ruiz MÁ, Collantes Estévez E.
Reumatol Clin. 2008 Jan;4(1):37-9. doi: 10.1016/S1699-258X(08)71794-7.
2007
- Indication for Anti-TNF-alpha Treatment in Patients With Ankylosing Spondylitis in Spain.
Font Ugalde P, Muñoz Gomariz E, Collantes Estévez E; por el Grupo ISSAS español.
Reumatol Clin. 2007 Nov;3(6):251-6. doi: 10.1016/S1699-258X(07)73699-9
- Olive oil and the haemostatic system.
Lopez-Miranda J, Delgado-Lista J, Perez-Martinez P, Jimenez-Gómez Y, Fuentes F, Ruano J, Marin C.
Mol Nutr Food Res. 2007 Oct;51(10):1249-59. Review
- An apolipoprotein A-II polymorphism (-265T/C, rs5082) regulates postprandial response to a saturated fat overload in healthy men.
Delgado-Lista J, Perez-Jimenez F, Tanaka T, Perez-Martinez P, Jimenez-Gomez Y, Marin C, Ruano J, Parnell L, Ordovas JM, Lopez-Miranda J.
J Nutr. 2007 Sep;137(9):2024-8.
- Evaluación de las recomendaciones ASAS-EULAR para el tratamiento de la espondilitis anquilosante.
Veroz González R, Collantes Estévez E.
Reumatol Clin. 2007 Jul;3 Suppl 2:S39-42. doi: 10.1016/S1699-258X(07)73640-9.
- El intestino en la patogenia de las espondiloartritis.
Collantes Estévez E.
Reumatol Clin. 2007 Jul;3 Suppl 2:S29-32. doi: 10.1016/S1699-258X(07)73637-9
- Two independent apolipoprotein A5 haplotypes modulate postprandial lipoprotein metabolism in a healthy Caucasian population.
Moreno-Luna R, Perez-Jimenez F, Marin C, Perez-Martinez P, Gomez P, Jimenez-Gomez Y, Delgado-Lista J, Moreno JA, Tanaka T, Ordovas JM, Lopez-Miranda J.
J Clin Endocrinol Metab. 2007 Jun;92(6):2280-5.
- Coordinated deregulation of cellular receptors, proangiogenic factors and intracellular pathways in acute myeloid leukaemia.
Barbarroja N, Arístides-Torres L, Hernandez V, Martín C, Dorado G, Torres A, Velasco F, Lopez-Pedrera C.
Leuk Lymphoma. 2007 Jun;48(6):1187-99.
- Increased efficacy of infliximab associated with methotrexate in ankylosing spondylitis.
Pérez-Guijo VC, Cravo AR, Castro Mdel C, Font P, Muñoz-Gomariz E, Collantes-Estevez E.
Joint Bone Spine. 2007 May;74(3):254-8
- Postprandial lipemia is modified by the presence of the APOB-516C/T polymorphism in a healthy Caucasian population.
Pérez-Martínez P, Pérez-Jiménez F, Ordovás JM, Moreno JA, Marín C, Moreno R, Jiménez-Gómez Y, Paniagua JA, López-Miranda J.
Lipids. 2007 Mar;42(2):143-50.
- Inhibition of Flt3-activating mutations does not prevent constitutive activation of ERK/Akt/STAT pathways in some AML cells: a possible cause for the limited effectiveness of monotherapy with small-molecule inhibitors.
Siendones E, Barbarroja N, Torres LA, Buendía P, Velasco F, Dorado G, Torres A, López-Pedrera C.
Hematol Oncol. 2007 Mar;25(1):30-7.
2006
- Vascular endothelial growth factor expression in monocytes from patients with primary antiphospholipid syndrome.
Cuadrado MJ, Buendía P, Velasco F, Aguirre MA, Barbarroja N, Torres LA, Khamashta M, López-Pedrera C.
J Thromb Haemost. 2006 Nov;4(11):2461-9.
- A single nucleotide polymorphism of the apolipoprotein A-V gene -1131T>C modulates postprandial lipoprotein metabolism.
Moreno R, Perez-Jimenez F, Marin C, Moreno JA, Gomez P, Bellido C, Perez-Martinez P, Jimenez-Gomez Y, Fuentes FJ, Lopez-Miranda J.
Atherosclerosis. 2006 Nov;189(1):163-8.
- Tissue factor as an effector of angiogenesis and tumor progression in hematological malignancies.
López-Pedrera C, Barbarroja N, Dorado G, Siendones E, Velasco F.
Leukemia. 2006 Aug;20(8):1331-40. Review.
- Antiphospholipid syndrome and tissue factor: a thrombotic couple.
López-Pedrera Ch, Buendía P, Aguirre MA, Velasco F, Cuadrado MJ.
Lupus. 2006;15(3):161-6. Review.
- Proteomic analysis of acute myeloid leukemia: Identification of potential early biomarkers and therapeutic targets.
López-Pedrera C, Villalba JM, Siendones E, Barbarroja N, Gómez-Díaz C, Rodríguez-Ariza A, Buendía P, Torres A, Velasco F.
Proteomics. 2006 Apr;6 Suppl 1:S293-9.
- Antiphospholipid-mediated thrombosis: interplay between anticardiolipin antibodies and vascular cells.
López-Pedrera C, Buendía P, Barbarroja N, Siendones E, Velasco F, Cuadrado MJ.
Clin Appl Thromb Hemost. 2006 Jan;12(1):41-5. Review.
- Antiphospholipid antibodies from patients with the antiphospholipid syndrome induce monocyte tissue factor expression through the simultaneous activation of NF-kappaB/Rel proteins via the p38 mitogen-activated protein kinase pathway, and of the MEK-1/ERK pathway.
López-Pedrera C, Buendía P, Cuadrado MJ, Siendones E, Aguirre MA, Barbarroja N, Montiel-Duarte C, Torres A, Khamashta M, Velasco F.
Arthritis Rheum. 2006 Jan;54(1):301-11.
2005
- Effectiveness of reducing infliximab dose interval in non-responder patients with refractory spondyloarthropathies. An open extension of a multicentre study.
Collantes-Estevez E, Muñoz-Villanueva MC, Zarco P, Torre-Alonso JC, Gratacós J, González C, Sanmartí R, Cañete JD; Spanish Spondyloarthropathies Study Group..
Rheumatology (Oxford). 2005 Dec;44(12):1555-8
- The apolipoprotein E gene promoter (-219G/T) polymorphism determines insulin sensitivity in response to dietary fat in healthy young adults.
Moreno JA, Pérez-Jiménez F, Marín C, Pérez-Martínez P, Moreno R, Gómez P, Jiménez-Gómez Y, Paniagua JA, Lairon D, López-Miranda J.
J Nutr. 2005 Nov;135(11):2535-40.
- The Ala54Thr polymorphism of the fatty acid-binding protein 2 gene is associated with a change in insulin sensitivity after a change in the type of dietary fat.
Marín C, Pérez-Jiménez F, Gómez P, Delgado J, Paniagua JA, Lozano A, Cortés B, Jiménez-Gómez Y, Gómez MJ, López-Miranda J.
Am J Clin Nutr. 2005 Jul;82(1):196-200.
- PGE1 abolishes the mitochondrial-independent cell death pathway induced by D-galactosamine in primary culture of rat hepatocytes.
Siendones E, Jiménez-Gómez Y, Montero JL, Gómez-Díaz C, Villalba JM, Muntané J.
J Gastroenterol Hepatol. 2005 Jan;20(1):108-16.
- Diagnostic strategies in spondylarthropaties.
Collantes Estévez E, Muñoz Gomariz E.
Rev Clin Esp. 2005 Jan;205(1):27-9
2004
- Bone Paget's disease in the young adult.
Collantes Estévez E, González Domínguez J.
Rev Clin Esp. 2004 Oct;204(10):505-6
- Tumour necrosis factor-alpha levels in aqueous humour and serum from patients with uveitis: the involvement of HLA-B27.
Pérez-Guijo V, Santos-Lacomba M, Sánchez-Hernández M, Castro-Villegas Mdel C, Gallardo-Galera JM, Collantes-Estévez E.
Curr Med Res Opin. 2004;20(2):155-7
- Tissue factor expression is decreased in monocytes obtained from blood during Mediterranean or high carbohydrate diets.
Bravo-Herrera MD, López-Miranda J, Marín C, Gómez P, Gómez MJ, Moreno JA, Pérez-Martínez P, Blanco A, Jiménez-Gómez Y, Pérez-Jiménez F.
Nutr Metab Cardiovasc Dis. 2004 Jun;14(3):128-32.
- Promyelocytic leukemia retinoid signaling targets regulate apoptosis,tissue factor and thrombomodulin expression.
López-Pedrera C, Barbarroja N, Buendía P, Torres A, Dorado G, Velasco F.
Haematologica. 2004 Mar;89(3):286-95.
- Pathogenic mechanisms of thrombosis in neoplasia: therapeutic implications.
López-Pedrera C, Barbarroja N, Velasco F.
Med Clin (Barc). 2004 Feb 14;122(5):190-6. Review.
